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Bone tissue engineering is employed to help enhance regeneration of bone tissue that
may have difficulty of achieving sufficient healing on its own. As bones tend to break in
irregular manners, methods to produce engineered scaffolds more closely fitting the geometry of
the defective tissue are desirable. Current techniques to produce engineered bone tissue
constructs result in stiff, rigid scaffolds with limited plasticity and ability to form irregular
architectures. Additionally, processing methods limit the feasibility to uniformly incorporate live
cells into the scaffolds for enhanced uniform healing. The use of hydrogel materials for bone
tissue engineering has gained interest due to their high water content and interwoven structure
mimicking that of the natural extracellular matrix, rendering them favorable for live cell
incorporation. Alginate is a hydrogel with materials properties allowing manipulation in a variety
of ways for numerous applications, including injectable fillers, 3D printing, drug and growth
factor delivery, cell encapsulation and many more.
In this work, the gelation properties of a series of alginate hydrogel formulations were
thoroughly studied and control of the gelation rate was established by varying component
concentrations. An optimal hydrogel system was developed with a gelation time appropriate in a
surgical setting and composition capable of aiding in new bone formation, confirmed through
various characterization techniques. A systematic investigation was then conducted using the
knowledge gained to determine the feasibility of their use in 3D printing. As a result, an alginate-
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polyvinyl alcohol-hydroxyapatite formulation was developed with optimal rheological properties
allowing encapsulation of MC3T3 cells and 3D bioprinting of scaffolds with high shape fidelity
and cell viability. Degradation studies showed the scaffolds maintained sufficient mechanical
stability to support cell life in culture. In vitro evaluations were then conducted to determine the
capacity of the formulations to support cell viability and promote cell proliferation. A synergistic
effect was discovered, highlighting the need for both sufficient cell adhesion modalities in the
matrix and appropriate scaffold mechanical rigidity.
Thus, the development of these alginate hydrogel systems can provide more personalized
treatment options for bone repair with potential to enhance bone tissue regeneration.
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Chapter 1
Introduction
1.1 Personalized medicine and tissue engineering
The recent advancement of personalized medicine involves individualized treatment to meet
the specific needs of patients on a case to case basis as opposed to employing a “one size fits all”
mentality. When considering defective tissue, one method of treatment may not be suitable for
all patients. Depending on the severity of the injury or damage, some patients may need
complete tissue replacement or transplantation whereas some may benefit from tissue repair.1
Tissue engineering, the use of biomaterials alone or in combination with cells and/or growth
factors, has been extensively practiced in hope to enhance healing of all tissue types.2,3 When
suitable, this method provides an alternative to tissue and organ transplantation. This alleviates
reliance on the limited availability and negative side effects associated with the use of donor
tissue, such as tissue rejection and encapsulation.4-6 The practice of tissue engineering involves
the production of biomaterial scaffolds used as tissue substitutes and reinforcements that promote
faster healing of the natural tissue while the defected area undergoes regeneration.7,8 It is of the
most importance that the material of choice be biocompatible, not eliciting an adverse immune
response from the host, and biodegradable, degrading within the body at the same rate it
promotes new tissue ingrowth for optimized healing.9,10

1.2 Bone tissue engineering
Natural bone is composed of inorganic hydroxyapatite (HA) minerals and organic
collagen fibrils.11 Thus, tissue engineering applied to enhance bone regeneration employs
biomaterials most often incorporating a combination of HA, collagen, and/or additional materials
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with composition and innate material properties closely resembling those of natural bone.12-14 It
is also of interest that these materials be osteoconductive, promoting bone growth on the surface
of the material, and osteoinductive, inducing the native in vivo environment to produce new
bone.15,16 Originally, the most common materials used were ceramics composed of calcium
phosphates.17 Conventional methods to construct such scaffolds include porogen leaching,
solvent casting and lyophilization, creating stiff structures with controlled porosity.18,19 Porosity
is necessary for nutrient transport and cellular migration throughout the scaffold, which are both
essential for new bone formation.20 However, these materials can often form brittle structures
lacking the elasticity of natural bone.21 Thus, additional polymeric materials, such as
polycaprolactone (PCL), polylactic acid (PLA), and polyglycolic acid (PLGA), have been
implemented in combination with osteoconductive materials such as HA, to increase the
elasticity of the scaffolds while maintaining sufficient mechanical strength, biocompatibility and
biodegradability.22,23 However, these scaffolds still suffer from limited ability to easily fit
irregular shaped defects, often created by bone fractures.24 Thus, recent research in bone tissue
engineering has focused on hydrogel materials which although are significantly weaker, are able
to form scaffolds of irregular dimensions, making them ideal for the practice of personalized
medicine and treatment of individualized defective tissues.

1.3 Hydrogel biomaterials
Hydrogels are composed of long chains of polymeric networks and are able to retain a
large quantity of water due to hydrophilic functional groups on the polymer backbone.25
Hydrogel biomaterial applications range from the formation of physical products such as contact
lenses and wound dressings, to their application in tissue engineering, drug delivery, cell
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encapsulation and 3D printing.26-30 They are often highly biocompatible and flexible due to their
high water content (over 90%) and interwoven structure resembling that of the natural
extracellular matrix (ECM), making them a favorable environment for cellular activities such as
migration and proliferation.31,32
Hydrogels are most often formed via sol-gel polymerization in which they transition from
a fluid, flowing state (sol) to a solid, non-flowing state (gel).33 Thermogelation is a sol-gel
mechanism in which the transition is induced at a particular temperature, most often body
temperature (37 °C) for biomedical applications.34 Figure 1.1 depicts the thermogelation of a
polyethylene glycol (PEG)-PCL-PEG-collagen-nanohydroxyapatite (PECE-collagen-nHA)
hydrogel occurring at 37 °C.34

Figure 1.1: Sol-gel transition of PECE-collagen-nHA hydrogel at 37 °C 34
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An alternative method is photopolymerization, which occurs as a result of polymerization of an
acrylic or methacrylic side group on the polymer backbone in the presence of a photoinitiator
and UV light.35,36 Additional sol-gel polymerization methods include those that are ionic and
result from chemical reactions, only occurring under a specific set of conditions.37,38 These
transitions are often easier to control and vary the materials properties of the resulting hydrogel,
including mechanical strength and degradation rate. They are also more biocompatible due to the
absence of cytotoxic side groups and non-biodegradable byproducts, commonly associated with
photopolymerization and thermogelation, respectively.39,40
Hydrogels can be either of synthetic or natural origin, both extensively researched for use
as biomaterials. Popular synthetic hydrogels, commonly formed through thermogelation and
photopolymerization, include PEG, polyhydroxyethyl methacrylate (PHEMA), and polyvinyl
alcohol (PVA).41,42 Natural hydrogels include chitosan, gelatin, and alginate, all derived from
natural sources.43,44 Although hydrogels are often implemented for soft tissue regeneration such
as skin and muscle, recent research has expanded into bone tissue engineering, though less
commonly explored.45,46

1.4 Alginate hydrogels
1.4.1 Composition
Alginate is a naturally occurring polysaccharide derived from brown algae.47 The linear
co-polymer backbone is composed of consecutive blocks of (1–4) linked α-L-guluronate (Gblocks) and β-D-mannuronate (M-blocks) followed by segments of alternating MG blocks.48
Figure 1.2 shows the composition of the G and M blocks.
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Figure 1.2: Polymeric structure of alginate 48

Alginate hydrogels will have specific materials properties according to the source, or type
of algae, it is derived from. This can be attributed to the ratio of G to M blocks present in the
polymer backbone, which varies from source to source.49 For example, sources with a high ratio,
or high G block content, such as Laminaria hyperborea, are known as high viscosity sources,
and form strong hydrogels. Medium viscosity sources, such as Macrocystis pyrifera, form
medium strength hydrogels due to the medium ratio of G:M blocks, while low viscosity sources
such as Ascophyllum rodosum, form the weakest hydrogels due to the high content of M blocks
within the polymer structure.49 The composition of the alginate polymer chains is responsible for
gelation and mechanical properties, which will be further explained in the next section.

1.4.2 Gelation and mechanical properties
The mechanism in which alginate experiences a sol-gel transition is ionic in nature. The
G blocks of the alginate polymer chain undergo formation of what is described as an “egg box”
structure in the presence of divalent cations.50 The divalent cations form intermolecular bonds

5

with two deprotonated carboxylate groups and two hydroxyl groups of the alginate G blocks,
shown in Figure 1.3. Lateral crosslinking of these egg boxes results in hydrogel formation.

Figure 1.3: Ionic crosslinking mechanism of alginate G blocks with calcium ions51

As previously mentioned, the ratio of G to M blocks in the alginate structure plays a
crucial role in the materials properties of the resulting hydrogel, as the G blocks have a great
affinity for divalent cations whereas the M blocks form weak interactions with divalent cations
and don’t partake in crosslinking.52 Thus, the greater amount of G blocks present in the structure,
the greater number of crosslinks formed, and the stronger the resulting hydrogel will be. Calcium
is the most commonly used divalent cation to induce alginate gelation as the G blocks have a
high affinity for forming strong bonds with it and it is the most biocompatible.53 Additional
divalent cations used include magnesium, barium and strontium, forming bonds weakest to
strongest, respectively.54
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The rate in which this gelation occurs can be tailored via varying the concentrations of
the constituents and/or the addition of retardation agents.52 It has been shown that an increase in
calcium concentration results in an increase in gelation rate, as the increase in available calcium
ions allows crosslinks with alginate G blocks to form quickly. The addition of a retardation such
as Na2HPO4 can interrupt the gelation process thereby slowing the rate in which it occurs.55 The
calcium source also plays a role in the gelation rate, with highly soluble sources such as CaCl2
releasing ions rapidly into the media supplying ions for immediate gelation. Intermediate sources
such as CaSO4, supply ions over time for gradual gelation, and sources with low solubility such
as CaCO3, supply ions over an extended period of time resulting in slow gelation.55 Thus, the
gelation rate can be tailored ranging from immediate, in which alginate microbeads are formed
instantly, to over a desired amount of time to achieve gradual gelation for injectable and filling
purposes.

1.4.3 Degradation mechanism
The mechanism by which alginate hydrogels degrade is through a natural ion exchange
with sodium ions or other monovalent ions in the surrounding environment.56,57 As the alginate
G blocks only form strong bonds with divalent cations, as monovalent ions replace them in the
egg box structure, the crosslinks are destroyed. This results in media uptake and swelling of the
hydrogel structure. Over time, as more crosslinks are broken, the gel will lose its mechanical
stability and break down into small pieces. As this process is not enzymatic, alginate is a
favorable option for use in the body as it won’t be broken down immediately by enzymes or
macrophages.58 Thus, alginate hydrogels have the capability of remaining within the body for
time periods necessary to support tissue regeneration. As previously discussed, as the extent of
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crosslinking directly affects the mechanical properties and stability of alginate hydrogels, their
degradation can be tailored to match the required time necessary for the application. Highly
crosslinked, stronger gels will maintain their integrity longer than weaker gels with fewer
crosslinks.

1.4.4 Applications
Alginate hydrogels have been extensively researched and used in a wide variety of
applications ranging from thickening agents in foods to immobilization agents and scaffold
systems in tissue engineering.52,54 As previously discussed, alginate’s innate biocompatibility
renders it favorable for use in many biomedical applications. It’s gelation properties allow
encapsulation of cells, drugs, growth factors for treatment of a variety of aliments including
infections, ulcers and wound healing.59,60 Alginate has been extensively studied for
implementation in wound healing in the form of wound dressings as thin films are easily
achievable through control of its gelation properties.61 As an alternative to gauze, alginate
provides exudate absorbance properties, water retention for a moist environment, and the ability
to incorporate antibiotics and other healing agents within the gel while enhancing skin
regeneration.62 The ability for alginate to serve as delivery vehicles, cell encapsulation and an
injectable systems will be further discussed in the following sections.

1.4.4.1 Delivery vehicles
The formation of alginate microspheres, most often as a result of immediate crosslinking
in CaCl2, is favorable for many applications. In pharmacology, drugs can be homogeneously
mixed throughout an alginate suspension and effectively trapped within the alginate matrix once
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the calcium crosslinks are formed. 63,64 Alginate microspheres can used for oral intake or be
injected and transported to the site of interest to deliver the drug of choice, such as antibiotics or
anti-inflammatory drugs, thus increasing the bioavailability and avoiding rapid drug clearance.6567

As alginate is not degraded enzymatically, the drugs are released via diffusion out of the

matrix or erosion of the microbeads.68 Additionally, burst release of the drug can be suppressed
and controlled release can be achieved by coating the microspheres or adding additional
biomaterials to form composite drug carrier systems. 69,70 Alginate-HA composite beads for oral
drug delivery can be seen in Figure 1.4.70 This method also allows for the incorporation of multidrug systems which may be difficult to obtain through conventional methods.52
Proteins and growth factors such as VEGF can also be encapsulated in microbeads or
bulk hydrogels and released in a controlled manner over an extended period of time to enhance
tissue regeneration in a defected area.71-73

Figure 1.4: Alginate-HA microbeads for drug delivery70
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1.4.4.2 Cell encapsulation
Similar to drug and growth factor encapsulation, live cells can also be mixed
homogeneously throughout an alginate suspension and immobilized via crosslinking with
calcium or other divalent cations.74-76 As the gelation rate can be easily tailored as previously
described, mild conditions not harmful to the cells can be achieved, such as gradual gelation at
room or body temperature, attributing to high cell viability.77 Thus, these “donor” cells can be
encapsulated and delivered to an area of defective tissue to help enhance regeneration. For
example, fibroblasts can be delivered to a wound site to secrete biological agents promoting
deposition of ECM components, leading to new epithelial tissue formation.78 Donor cells can
also release chemical signals to recruit host cells to invade the defected area and begin to form
new tissue as well.
Although cells can be easily encapsulated in alginate at high viability rates, the matrix
must resemble that of the native extracellular matrix in order for cells to proliferate, differentiate,
and begin new tissue deposition.79 Cells need to attach and migrate throughout their extracellular
matrix in order to form a network and carry out appropriate physiological behaviors such as
proliferation. In the native ECM, elements such as ligands, cell adhesion molecules (CAMs) and
additional proteins exist that promote binding to integrins, or transmembrane receptors, on the
cytoskeleton.80 Alginate alone has been reported to induced limited interactions with cells due to
its polymer structure, providing minimal cell adhesion sites.81,82 As alginate does not promote
formation of these adhesive contacts, elements that possess ligands, such as collagen and
fibronectin, are often added to enhance cellular interactions within the hydrogel matrix.83,84
Alternatively, the alginate polymer backbone can be chemically modified and coupled with RGD
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peptides to mimic the presence of adhesion proteins in the matrix and promote integrin
binding.85,86
Furthermore, the alginate hydrogel matrix is often combined with additional elements to
promote cellular differentiation and progression of mature cells capable of depositing new tissue
of choice. For example, tissue engineered constructs aimed to promote new bone formation often
include collagen and hydroxyapatite, the main components of natural bone.87 Thus, preosteoblastic cells will sense an environment simulating natural bone and will be more inclined to
differentiate into osteoblasts.

1.4.4.3 Injectable purposes
Control of the gelation kinetics of alginate also renders it an optimal base system for
injectable applications such as dermal fillers and wound dressings. Injectable hydrogels can also
be used to treat additional tissue defects including cartilage and bone, which has been less
extensively investigated.37 In general, treatment via injectable means are favored because they
are less invasive and don’t require open surgery, which is associated with more pain and longer
healing times for patients. Thus, injectable options are most often preferred as they improve the
quality of patients’ lives during healing, which is a vulnerable time period. Alginate hydrogel
injectable systems are advantageous as the gelation rate can be controlled to completely fill a
tissue defect and set as a mechanically stable gel within minutes.38 Thus, irregularity in defect
geometry is not an issue, which can be the case when using other static materials or scaffolds
constructed under conventional methods.24 As previously discussed, applying injectable
hydrogels for treatment of defected bone tissue is especially favorable as bone most often breaks
in irregular manners.
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Additionally, as discussed in the previous section, drugs, growth factors, cells, and
additional biological components can be encapsulated within the alginate hydrogel and injected
into a defected tissue area to aid in enhanced regeneration, thus combining many treatment
elements and methods into one superior alternative.

1.4 Three-Dimensional Printing
Three-dimensional (3D) printing is an additive manufacturing technique that implements
the production of structures layer by layer.88 First, a 3D CAD model is created of the desired
structure, saved as a .stl file and sliced into G-code, or the computer language that 3D printing
software reads. The G-code file dictates the path in which the extruder should follow in order to
deposit the material in a way that results in the desired structure.89 Then, the user chooses various
printing conditions, such as printer speed and flow rate, to instruct the printer on how the
material should be deposited. 3D printed structures can then be printed ranging from minutes to
hours, depending on the size and complexity of the CAD design.90
Many types of 3D printing methods exist each with specific requirements for the
materials used. 3D printing of metals involves direct metal laser sintering (DMLS), a process in
which a laser is directed at a bed of metal powder and melts the metal selectively, fusing the
particles into the desired structure.91 Similarly, inkjet printing, also known as binder jetting,
requires deposition of a powder resin followed by printing a layer of a liquid binder material to
selectively bind particles together.92 Stereolithography, often denoted as the first rapid
prototyping technique, utilizes a laser to spatially control the photopolymerization of a liquid
resin.93 When the current layer is cured, more resin is added to pattern and cure the succeeding
layer. A popular polymer 3D printing method includes fused deposition modeling (FDM), in
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which a filamentous thermoplastic is required to melt upon heating and re-solidify once
deposited, thereby fusing with the previous layer. Materials employed often include synthetic
polymers such as PCL and PLGA.94 Although all of the previously discussed methods are
capable of producing 3D structures of high shape fidelity and mechanical strength, limitations
exist when employing these methods for 3D printing for tissue engineering. Reconstruction of
damaged or defective tissue can be achieved via 3D printing of repaired CAD files obtained from
a patient’s MRI or CT scan, thus producing individualized structures with precise geometry and
porosity necessary for enhanced tissue healing.95 A schematic of the 3D printing process is
shown in Figure 1.5.

Figure 1.5: Schematic of 3D printing process 96
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As previously mentioned, tissue regeneration can be enhanced even further via inclusion
of a patient’s own cells distributed homogeneously throughout the engineered tissue substitute.
Thus, 3D “bioprinting” or printing of live cells within a biomaterial into scaffolds has emerged
and progressed rapidly in hope to achieve such advanced healing.97-99 Conventional 3D printing
processing techniques include chemical components or high temperatures making them
unsuitable for incorporation of live cells. Thus, as hydrogels are extensively used for cell
encapsulation, 3D printing of hydrogels with more gentle techniques such as piston-driven
extrusion have recently been implemented.100
Alginate is an ideal candidate for 3D bioprinting due to its innate material properties. An
example of a 3D bioprinted alginate scaffold for encapsulating endothelial cells is shown in
Figure 1.6. 98 Alginate’s rheological properties allow shear-thinning, or a reduction in viscosity
under increased shear.101 This attribute is favorable for 3D printing as a less viscous material
requires less stress and pressure to be extruded through a nozzle. Thus, cells encapsulated within
alginate are subjected to less stress. Additionally, the formation of crosslinks between alginate G
blocks and divalent cations can form a protective barrier for the cells, sheltering them from
applied pressure.
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Figure 1.6 3D printed alginate scaffold 98

1.5 Current shortcomings
Although there are emerging biomaterials and technology capable of treating patients on
an individual basis for tissue regeneration, there remains a few limitations present in the field.
For example, personalized treatment is less popularly applied to bone tissue regeneration due to
the relatively weak structures formed with hydrogel materials. However, injectable hydrogels
have the capability of completely filling irregular shapes not achievable by conventional scaffold
processing techniques, which result in rigid scaffolds of limited plasticity. Additionally, these
rigid scaffolds pose difficulties for uniform cell infiltration via traditional seeding techniques.
Similarly, 3D printing methods used to produce scaffolds for bone tissue regeneration have
largely focused on producing structures composed of calcium phosphates of high mechanical
strength, shown in Figure 1.7.92 As a result, the feasibility of incorporating of live cells within
the biomaterial and printing structures with high cell viability is limited.102,103 Thus, there is a
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need to progress the practice of bone tissue engineering towards a more individualized healing
practice, which can be achievable through the use of hydrogels such as alginate.

Figure 1.7 3D printed scaffolds for bone tissue engineering 92

1.6 Research objectives
As previously discussed, hydrogel systems for individualized treatment for enhanced
bone tissue regeneration is less commonly explored. However, they have the potential to provide
patients with scaffolds of perfectly fitting geometry to heal their specific defects as well as
incorporate the patients’ own cells within the matrix for the possibility of enhanced,
homogeneous regeneration and healing.
Thus, the objective of this research is to develop a novel hydrogel system capable of
multiple applications for enhanced, individualized treatment and regeneration of defective bone
16

tissue. Alginate was chosen as the hydrogel base element due to its biocompatibility,
biodegradability, and ability to readily mix with additional components while maintaining its
innate gelation properties. An alginate-collagen-hydroxyapatite hydrogel system was developed
and the gelation properties were thoroughly investigated. Establishment of control of the gelation
kinetics to result in a system suitable for injectable applications was of interest, as it is crucial the
hydrogel formulation completely fills a defect and sets in an appropriate amount of time.
Collagen was incorporated and hydroxyapatite was formed in situ, confirmed through various
characterization techniques, resulting in an environment more closely mimicking natural bone
and providing elements capable of contributing to enhanced bone regeneration. We next aimed to
develop a hydrogel system for 3D bioprinting for scaffolds capable of supporting cell life and
enhanced, individualized bone defect regeneration. A systematic investigation based on the
previously well-established knowledge of the properties of alginate gelation led to the
development of a novel alginate-polyvinyl alcohol-hydroxyapatite system suitable for 3D
printing. The printability of various concentrations and combinations of components were
studied via 3D printing and rheology to understand rheological properties necessary to allow the
hydrogel to be easily extruded and recover upon deposition to create 3D scaffolds of high shape
fidelity. As the main goal was to bioprint live cells into the scaffolds with high viability, scaffold
degradation properties were investigated to determine if they maintained mechanical stability
and had the capacity to support cell life in vitro. MC3T3 cells were then incorporated into the
alginate system and 3D bioprinted at high viability. In vitro evaluations of 3D bioprinted
alginate-polyvinyl alcohol-hydroxyapatite scaffolds were then conducted to assess the scaffolds’
ability to support cell life and proliferation. A systematic study to increase cell proliferation was
conducted, including investigations of the effects of the calcium bath and addition of collagen
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gel on proliferation. This shed light on the components necessary to support cell proliferation
and led to the development of a novel tri-polymer hydrogel network capable of 3D bioprinting
and supporting cell proliferation and potential to support differentiation in vitro.
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Chapter 2
Synthesis and characterization of a novel injectable alginate–collagen–hydroxyapatite
hydrogel for bone tissue regeneration

2.1 Introduction
Bone tissue engineering scaffolds have been researched extensively in hope to find an
ideal construct that is biocompatible, biodegradable, promotes bone regeneration and mimics the
distinctive properties of natural bone. It is especially important that the composition closely
resembles that of bone and the native extracellular matrix in order to promote favorable cell
attachment and proliferation. The main components of natural bone found in the human body
include inorganic hydroxyapatite nanocrystals and organic collagen fibrils.11 The first bone tissue
engineered scaffolds aimed to mimic the composition of natural bone and possess regeneration
capabilities were developed in the form of calcium phosphate ceramic implants.103,104 Since then,
calcium phosphate cements and scaffolds have been constructed in combination with various
biopolymers such as polycaprolactone, chitosan and collagen to produce biocompatible
composites capable of promoting bone regeneration.12,13,17,105–107 Specifically, a well known coprecipitation method first developed by Kikuchi et al. has been followed to fabricate scaffolds in
which hydroxyapatite nanocrystals are nucleated onto collagen fibers that precipitate out of
solution.108 Many variations of this self-assembling method have since been established.19,109
Recently, our group has developed a novel co-precipitation method involving the nucleation of
apatite onto collagen fibers in a modified simulated body fluid (m-SBF).110,111 These lyophilized
scaffolds have been proven to be biocompatible and promote new bone growth.112
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Despite the early success in the preparation of lyophilized bone tissue engineering
scaffolds, they must be surgically implanted into the bone defect of the patient. Thus, researchers
have been gravitating towards the development of novel, noninvasive, injectable hydrogel
scaffolds for bone tissue engineering. The current most widely used technique is the use of sol–
gel polymerization. Sol -gel mechanisms include photopolymerization, thermogelation,
concentration dependent chemical reactions and various additional mechanisms.34,113,114
Photopolymerization techniques involve the radical chain polymerization of a polymer in which
an acrylic or methacrylic side group is initiated and polymerized by a photoinitiator (I2959)
under UV light.113 Similarly, many thermogelation techniques involve the monomeric
polymerization of polymers with non-degradable backbones, for example pNiPAAm based
polymers, which introduces side groups that are potential cytotoxic agents.115,116 This possibility
of cytotoxicity and additional adverse immune responses render these polymer modification
processes less biocompatible for injectable hydrogel purposes. Thus, injectable systems without
polymeric modification such as ionically crosslinked systems are more suitable.
An extensively researched ionically crosslinked injectable hydrogel system includes the
use of the naturally occurring polysaccharide alginate, produced by brown algae such as
Macrocystis pyrifera (kelp).117 Applications in which alginate is used range from food stabilizers
in ice cream to biomedical applications such as dental molds, wound dressings, cell
immobilization, drug delivery and bone tissue engineered scaffolds.54,77,118,119 Alginate is a linear
co-polymer composed of consecutive blocks of (1–4) linked a-L-guluronate (G-blocks) and b-Dmannuronate (M-blocks) followed by segments of alternating MG blocks.58 Grant et al. first
described the formation of an ‘‘egg box structure’’ as a result of the G blocks in the presence of
divalent cations such as calcium, barium and strontium. 50 The divalent cations form
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intermolecular bonds with two deprotonated carboxylate groups of one G block and with two
hydroxyl groups of another.120 The β- glycolic linkage of the M blocks has a low affinity for
divalent cations, resulting in weak interactions. The G blocks are therefore most significant in the
crosslinking process.121 As a result of this crosslinking of lateral egg box multimers, the alginate
undergoes a sol–gel transition.114
Martinsen et al. found that the sol–gel transition occurs instantaneously to form alginate
gel microspheres when alginate is added dropwise to a calcium chloride solution.118 Although
this property may be favorable for some applications such as cell immobilization, the fast
gelation rate may not be ideal for others, such as injectable purposes.77 Cho et al. proposed the
use of CaSO4 as a gelling agent and Na2HPO4 as a retardation agent to control the gelation rate
of an alginate gel.55 Controlling the gelation rate allows for homogeneous gel formation and
uniform material properties.38
Unfortunately, alginate on its own has shown to induce reduced cell attachment in vitro
due to its hydrophilic and negatively charged properties as well as poor osteoconductivity.58
Therefore researchers have expanded to using combinations of alginate with more biocompatible
components such as PVA, hydroxyapatite, collagen and chitosan.55,122–125 Particularly, the
combination of alginate, collagen and hydroxyapatite has been extensively researched.119,87,125,126
Commonly, pre-fabricated, lyophilized collagen-apatite powder is added to an alginate
suspension which is then gelled and lyophilized for further characterization. In vitro studies have
shown that the addition of collagen and hydroxyapatite to the alginate hydrogel provided a
favorable environment for osteoblast attachment and proliferation.87 Thus, the focus of our work
in this chapter was to develop a novel combination of an injectable alginate–collagen hydrogel
with in situ hydroxyapatite nucleation onto collagen fibers. This combination provides
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appropriate mechanical strength as a bone tissue substitute and the components necessary to
promote bone regeneration without lyophilization, proving its potential as an injectable
regenerative material.

2.2 Materials and methods
2.2.1 Preparation of alginate hydrogels
Alginic acid sodium salt (medium viscosity; MP Biomedicals LLC, USA) was added to 6
mL of deionized water in polystyrene vials (25.9 mL; ID x H: 26 x 51 mm) and mixed with 2 mL
of sodium phosphate dibasic anhydrous (Na2HPO4, ≥ 99%, Fisher Scientific, USA) solutions at
varying concentrations according to Table 2.1. The suspensions then sat for 1 hour at room
temperature before 8 mL of calcium sulfate anhydrous (CaSO4, 99%, Alfa Aesar, USA) solutions
of varying concentrations were added and mixed for 30 seconds. The gelation time was observed
and recorded as defined by the test tube tilting method.31 Briefly, the vial was tilted 90° every
minute after initial mixing and the time at which the meniscus of the suspension no longer
moved was designated as the gelation point. As shown in Table 1, the final weight percent of
alginate was 1.5% (w/v) while the final weight percentages of Na2HPO4 and CaSO4 ranged from
0–0.12% (w/v) and 0.20–0.40% (w/v), respectively. Alginate hydrogels with 0.12% (w/v) P
(Na2HPO4) and 0.40% (w/v) Ca (CaSO4) were chosen for the addition of pure collagen fibers
and mineralized collagen fibers.
After the gelation test, A–P-4, A–P-5 and A–P-9 hydrogels were chosen to proceed with
mechanical testing as their gelation times fell in the range of 5–30 minutes, defined as ideal in a
surgical setting.126 The A–Ca-1 hydrogel was selected to act as the control.
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Table 2.1: Compositions of A-Ca and A-P hydrogels
Hydrogel
A-Ca-1
A-Ca-2
A-Ca-3
A-P-1
A-P-2
A-P-3
A-P-4
A-P-5
A-P-6
A-P-7
A-P-8
A-P-9

Alginate
Final % (w/v)
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5

CaSO4
Final % (w/v)
0.20
0.30
0.40
0.20
0.30
0.40
0.20
0.30
0.40
0.20
0.30
0.40

Na2HPO4
Final % (w/v)
0
0
0
0.04
0.04
0.04
0.08
0.08
0.08
0.12
0.12
0.12

2.2.2 Preparation of alginate–collagen (A–C) hydrogels
Type I collagen was extracted from rat tails following a protocol by Rajan et al.127
Briefly, the collagen was extracted and dissolved in 0.02 M acetic acid at 4°C. The pH of the
collagen solution was raised to 7 using sodium hydroxide. 30 mL of the collagen solution with a
concentration of 4.5 mg/mL was then covered placed in a waterbath at 37 °C for 24 hours at
constant stirring using a magnetic stir bar and stir plate. The precipitates were then collected via
filtration and rinsed with deionized water. The fibers were then allowed to air dry for 1 hour. A
small amount of fibers was air dried overnight and imaged using FESEM to observe the
morphology.
Final compositions of the A–C hydrogels can be seen in Table 2.2. Collagen fibers were
added at 2.5, 5.0, 10.0 and 20.0% (w/v) to alginate suspensions and mixed until homogeneously
distributed throughout the alginate suspensions. Na2HPO4 solution was added to the mixture
after 20 minutes at 0.12% (w/v) of the final hydrogel. After 1 hour, CaSO4 solution of 0.40%
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(w/v) of the final hydrogel volume was added and the gelation time was recorded as previously
described.

Table 2.2: Composition of A-C and A-MC hydrogels
Hydrogel

Alginate
Final % (w/v)

CaSO4
Final % (w/v)

Na2HPO4
Final % (w/v)

A-C-1
A-C-2
A-C-3
A-C-4
A-MC-1a
A-MC-1b
A-MC-2*

1.5
1.5
1.5
1.5
1.5
1.5
1.5

0.40
0.40
0.40
0.40
0.40
0.40
0.40

0.12
0.12
0.12
0.12
0.12
0.12
0.12

Pure Collagen
Fiber
Final % (w/v)
2.5
5.0
10.0
20.0
0
0
0

Mineralized
Collagen Fiber
Final % (w/v)
0
0
0
0
2.5
5.0
2.5

*Phosphate solution was added to mineralized collagen suspension before the addition of
alginate powder

2.2.3 Preparation of alginate–mineralized collagen (A–MC) hydrogels
Alginate–mineralized collagen (A–MC) hydrogels were composed of alginate,
mineralized collagen fibers, Na2HPO4 and CaSO4. A–MC hydrogels differed in the order in
which the remaining components were added to the mineralized collagen fiber suspension. A–
MC-1 hydrogels were prepared by adding alginate powder prior to the phosphate solution
addition whereas for A–MC-2 hydrogels, the phosphate solution was added prior to the alginate
powder. To prepare mineralized collagen fibers, a solution of modified simulated body fluid (mSBF) was used as the source to provide calcium and phosphate ions.13,15 Briefly, SBF is
composed of inorganic ions similar to the natural composition of human blood plasma. The
modified SBF contains ion concentrations 3 times that of normal SBF to ensure mineralization of
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collagen fibers. The first two salts in the m-SBF recipe were dissolved in 20 mL of deionized
water. A collagen solution of concentration 4.5 mg/mL was then added to the solution and mixed
on ice for 10 minutes. The next 3 salts were added to 10 mL of deionized in order after the
complete dissolution of the previous ion. This solution was then added to the collagen solution
containing the first two ions, which remained on ice, and mixed for an additional 10 minutes.
The sodium bicarbonate was added to the collagen–SBF solution and mixed until completely
dissolved. The pH of the solution was raised to 7 using sodium hydroxide. The collagen–SBF
solution was then removed from ice and added to a waterbath at 37 °C under moderate stirring
for 1.5 hours. The stir bar was then removed and the suspension was aged at 37 °C overnight.
After 24 hours, the mineralized collagen fiber precipitates were collected via filtration, rinsed
twice with deionized water and allowed to air dry. The fibers were weighed at 2.5 and 5.0%
(w/v) of the final hydrogel. The fibers were re-suspended in 6 mL of deionized water under
moderate stirring to re-disperse them in the suspension. For A–MC-1 hydrogels, 0.24 g alginate
powder was then added to the collagen suspension and mixed to form a homogeneous
suspension. 0.12% (w/v) P and 0.40% (w/v) Ca solutions were then added as previously
described. The final A–MC-1 hydrogel compositions can be seen in Table 2.2. The gelation time
was recorded according to the test tube tilting method as previously described.
To further investigate gelation properties, A–MC-2 hydrogels (2.5% w/v) were prepared.
Mineralized collagen fibers, prepared as previously described, were added to deionized water
followed by an addition of the phosphate solution at 0.12% (w/v) of the final hydrogel. Alginate
powder was then added to the solution at a final concentration of 1.5% (w/v). CaSO4 at 0.40%
(w/v) final concentration was added and gelation proceeded as previously described.
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2.2.4 Characterization
The morphology of pure collagen fibers and mineralized collagen fibers were observed
using field emission scanning electron microscopy (FESEM, JEOL JSM-6335F, Japan) at an
accelerating voltage of 5 kV.
Dynamic mechanical analysis (DMA) was completed using a DMA 2980 Dynamic
Mechanical Analyzer (TA instrument Inc., New Castle, DE) in compression mode using 40 mm
sandwich fixtures. Pre-determined A–Ca (n = 8) and A–P (n = 8) hydrogel samples were sliced
to an average thickness of 4.5 mm. The hydrogels were loaded into the DMA, ramped to 37 °C
and held isothermally for 5 minutes. A preload force of 0.01 N was applied, followed by a force
ramped up to 18 N at a uniform stress rate of 0.5 N per minute. The compressive modulus was
determined from the slope of the initial 20% linear elastic region of the obtained stress–strain
curve. The same procedure was implemented for A–C (n = 5), A–MC-1 (n = 5) and A–MC-2
(n = 5) hydrogels.
After DMA testing, remaining hydrogel slices were frozen at -25 °C and lyophilized
using a freeze-dryer (Free Zones, Labconco, USA). The freeze-dried hydrogels of selected
compositions, as listed in Table 2.3, were subjected to a series of evaluations, including
thermogravimetric analysis (TGA), X-ray diffraction (XRD), and Fourier transform infrared
spectroscopy (FTIR).
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Table 2.3: Compositions of selected hydrogels for characterization of inorganic content
Hydrogel

A-Ca-1:
Alginate-CaSO4
A-P-9:
Alginate-Phosphate
A-C:
Alginate-Collagen
A-MC-1:
AlginateMineralized Collagen
A-MC-2:
AlginateMineralized Collagen

Alginate
% (w/v)

CaSO4
% (w/v)

Na2HPO4
% (w/v)

Collagen
Fibers
% (w/v)

Mineralized
Collagen Fibers
% (w/v)

1.5

0.20

0

0

0

1.5

0.40

0.12

0

0

1.5

0.40

0.12

2.5

0

1.5

0.40

0.12

0

2.5

1.5

0.40

0.12

0

2.5

TGA was conducted using a TG analyzer (TGA-1000, Rheometric Scientific, UK) to
determine the weight percentage of the inorganic components present in the hydrogels. The
freeze-dried hydrogels were loaded into the TG analyzer at an average weight of 20 mg. The
weight loss profile was recorded from 25 °C to 900 °C in air at a rate of 10 °C per minute and the
weight percent residue was determined. X-ray diffraction (XRD, Bruker AXS D5005) was
performed on the freeze-dried hydrogels to determine the composition of the inorganic
components present in the hydrogels. Scans were collected over a 2θ range of 10-50° at a step
size of 0.02° and a scan rate of 0.2° per minute with Cu Kα radiation (k = 1.54056 nm). FTIR
was used to determine the functional groups present in the alginate hydrogels. FTIR spectra were
obtained with a Nicolet Magna-IR 560 Spectrometer and a Specac-Onest Single Bounce
Diamond ATR Accessory. A small slice of the freeze-dried hydrogel was placed over the
diamond and compressed until sufficient contact was made. The spectra were recorded using 32
scans over the range of 400 to 4000 cm-1 using OMNIAC software.
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2.2.5 Statistical analysis
Results were statistically analyzed using one or two-way analysis of variance (ANOVA)
and expressed as mean ± standard deviation. Statistical significance was defined as p < 0.05.

2.3 Results
2.3.1 Gelation time
The solution and gel states of alginate are shown in Fig. 2.1.

Figure 2.1: Alginate suspension (left) and gel (right) states

Average gelation times of alginate hydrogels with varying CaSO4 and Na2HPO4 concentrations
are shown in Fig. 2.2. Within groups A–P-1-3 (0.04% (w/v) Na2HPO4) and A–P-7–9 (0.12%
(w/v) Na2HPO4), an increase in calcium concentrations resulted in a decrease in gelation time.
The slight increase in gelation times seen in groups A–Ca-1–3 (0% (w/v) Na2HPO4) and A–P-4–
6 (0.08% (w/v) Na2HPO4) was not statistically significant. Comparing gelation times of alginates
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composed of the same calcium concentrations displayed an increase in gelation time with
increasing Na2HPO4 concentration. Variations from this increase in gelation time were not
statistically significant. The control group exhibited variation from the expected increase in
gelation time due to the instantaneous, inhomogeneous gelation of the alginate chains and
hindered diffusion of calcium ions throughout the suspension. The differences in average
gelation times of the selected, starred hydrogels were not statistically significant from the
control.

Figure 2.2: Average gelation times of alginate hydrogels with varying Na2HPO4 and CaSO4
concentrations. *Statistically significant from each other (p < 0.05, ANOVA), ** selected
compositions for mechanical testing
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Fig. 2.3a displays a FESEM image of pure collagen fibers added to the alginate
hydrogels. The collagen fibers are about 200 nm in width and on the order of micrometers in
length. Debanding patterns characteristic of collagen fibers are observed. Fig. 2.3b shows a
FESEM image of mineralized collagen fibers in which apatite particles are deposited along the
collagen fibers.

a)

b)

Figure 2.3: FESEM images of air dried a) pure collagen fibers and b) mineralized collagen fibers
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The average gelation times of alginate hydrogels with varying weight percentages of pure
collagen fibers and mineralized fibers are shown in Fig. 2.4. The addition of pure collagen fibers
at all percentages did not significantly impact the gelation times of the hydrogels when compared
to the control. The addition of alginate directly following the mineralized fibers (A–MC-1
hydrogels) resulted in a decrease in average gelation times yet differences are not statistically
significant from the control. However, the average gelation times of A–MC-1 hydrogels (2.5%
w/v and 5% w/v) did display a statistically significant decrease compared to A–C-1 hydrogels
(2.5% (w/v) pure collagen fibers). When the order of the phosphate addition was modified to be
before the alginate (A–MC-2), the gelation time was not significantly different from the control
and was slower than those of A–MC-1 hydrogels. A statistically significant difference in gelation
time was observed between 5% (w/v) A–MC-1b and 2.5% (w/v) A–MC-2 hydrogels.

Figure 2.4: Gelation times of alginate hydrogels with varying pure collagen (C) or mineralized
collagen (MC) fiber content. *Statistically significant from each other (p < 0.05, ANOVA)
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2.3.2 Dynamic mechanical analysis
The average compressive moduli of alginate hydrogels of varying phosphate and calcium
concentrations are shown in Fig. 2.5. A–Ca-1 hydrogels (0 % (w/v) Na2HPO4; 0.20% (w/v)
CaSO4) displayed an average compressive modulus of 1.6 kPa. An increase to 0.08% (w/v) P and
0.20% (w/v) Ca increased the average modulus to 2.3 kPa. The addition of 0.08% (w/v) P and
0.30% (w/v) Ca increased the average modulus to 3.2 kPa. The average compressive modulus
peaked at a value of 5.1 kPa for alginate hydrogels of 0.12% Na2HPO4 and 0.40% CaSO4, which
was significantly higher than the other hydrogels.

Figure 2.5: Compressive moduli of alginate hydrogels of varying Na2HPO4 and CaSO4 content.
*Statistically significant from each other (p < 0.05, ANOVA)
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The average compression moduli of A–C and A–MC hydrogels are shown in Fig. 2.6. As
a result of the addition of pure collagen fibers at 2.5, 5 and 10% (w/v) to alginate hydrogels
composed of 0.12% P and 0.40% Ca, the compressive moduli of these hydrogels increased
significantly. The average compressive modulus peaked at a value of 7.5 kPa for A–C-1 (2.5%
(w/v)) hydrogels. The addition of alginate immediately after the mineralized collagen fibers (A–
MC-1) did not result in statistically significant differences in compressive moduli compared to
the control. The modulus of the A–MC-1a (2.5% (w/v)) hydrogels (6.6 kPa) was significantly
lower than that of A–C-2 (5% (w/v)) hydrogels. The modulus of the A–MC-1b hydrogels (5.9
kPa) was significantly lower than that of both the A–C-1 and A–C-2 hydrogels. When the
phosphate solution was added before the alginate (A–MC-2), the modulus reached the maximum
of 8.0 kPa. This increased value was statistically significantly different from the original A–MC
hydrogels (A–MC-1a and A–MC-1b) and the control.

Figure 2.6: Compressive moduli of various (a) A–C and (b) A–MC hydrogels. *Statistically
significant from each other (p < 0.05, ANOVA)
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2.3.3 Thermogravimetric analysis
The TGA profiles for alginate hydrogels of various compositions can be seen in Fig. 2.7.
Decomposition of the alginate hydrogels begins around 26 °C with the loss of water, followed by
the rupture of the alginate chains and monomers around 190 °C and 620 °C. The residue includes
elements that decompose above 900 °C. The average percent residue for A–Ca-1, A–P 9, A–C-1,
A–MC-1a (2.5% w/v) and A–MC-2 (2.5% w/v) hydrogels was determined to be 26.8%, 33.0%,
32.8%, 31.4% and 35.0%, respectively. The increase in percent residue with the addition of
phosphate, collagen fibers or mineralized collagen fibers to the control (A–Ca hydrogel) was
statistically significant for all samples. The addition of pure collagen fibers (A–C) or mineralized
collagen fibers (A–MC-1) did not result in a statistically significant increase in the percent
residue compared to the alginate phosphate hydrogel (A–P-9), nor were they statistically
significant from each other. The altered order of the addition of the phosphate solution (A–MC2) resulted in an increase in residue that was statistically significant from the A–Ca-1, A–C-1 and
A–MC-1a hydrogels.
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a)
b)
c)

Figure 2.7: TGA curves of alginate hydrogels containing (a) A–MC-2, (b) A–P-9 (0.40% Ca–
0.12% P) and (c) A–Ca-1 (0.20% Ca–0% P)

2.3.4 X-ray diffraction
Fig. 2.8 shows X-ray diffraction patterns of A–Ca-1, A–P-9, A–C-1, A–MC-1a and A–
MC-2 hydrogels. The A–Ca spectrum depicts characteristic peaks of sodium calcium sulfate
hydrate, sodium sulfate and calcium sulfate. The addition of phosphate to the A–Ca hydrogel
results in additional peaks of sodium hydrogen phosphate and calcium phosphate carbonate. The
addition of pure collagen fibers to the A–P hydrogels (A–C hydrogels) exhibits peaks
characteristic of carbonate apatite around 29° and 32°. The A–MC-1a hydrogel with mineralized
collagen fibers spectrum displays a greater amount of peaks characteristic of carbonatehydroxyapatite around 25° and 29° and calcium phosphate carbonate around 19°, 23°, 34° and
38°. The A–MC-2 spectrum displays peaks at the same positions as the A–MC-1a spectrum but
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with increased broadening. Peak broadening and shifting amongst spectra may be attributed to
the overlapping of peaks of the various components of the hydrogels.

Figure 2.8: XRD patterns of (a) A–Ca-1, (b) A–P-9, (c) A–C-1, (d) A–MC-1a and (e) A–MC-2
hydrogels

2.3.5 Fourier transform infrared spectroscopy
The FTIR spectra of A–Ca-1 (0.20% Ca), A–P-9 (0.40% Ca–0.12% P), A–C-1 (2.5%
pure collagen fibers), A–MC-1a (2.5% mineralized collagen fibers) and A–MC-2 (2.5%
mineralized collagen fibers) hydrogels are shown in Fig. 2.9. The alginate alone spectrum
displays characteristic alginate bands denoting asymmetric and symmetric stretching of –COO-1
modes, found at 1595 cm-1 and 1410 cm-1, respectively. C–O stretching vibration modes occur at
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1080 cm-1; and hydroxyl stretching bands at 3294 cm-1. Bending of the OH group of the carboxyl
is depicted at 889 cm-1. With the addition of phosphate, a shift of the –COO- bands to higher
wavelengths is observed. Bending and stretching of the phosphate modes are observed at 611
cm-1 and 997 cm-1, respectively. The addition of pure collagen fibers and mineralized collagen
fibers also results in a shift of the carboxyl absorption bands to higher wavelengths. Amide
absorption bands of the collagen fibers characteristic of C=O and O–H stretching, N–H
stretching and C–N stretching can be found at 1670 cm-1 and 1630 cm-1, 1550 cm-1, and 1200
cm-1, respectively. Stretching of the PO4 3- groups of the in situ formed apatite is located at
1200–965 cm-1 and 600–500 cm-1. All of these signature peaks of collagen overlap with
characteristic peaks of the A–Ca and A–P hydrogel systems.

Figure 2.9: FTIR spectra of (a) A–Ca-1, (b) A–P-9, (c) A–C-1, (d) A–MC-1a and (e) A–MC-2
hydrogels
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2.4. Discussion
2.4.1 Gelation time and mechanical properties
The ability to tailor the gelation time and strength of alginate hydrogels as desired is one
of the greatest incentives for using alginate in a variety of applications. For injectable hydrogels
used in bone tissue engineering, it is ideal that the composition can be adjusted so that the
gelation rate is slow enough to allow surgical handling yet fast enough for the hydrogel to
achieve in vivo stability and functionality soon after injection. The optimal gelation time range
has been defined as 5–30 minutes.126
The variation in gelation time among the alginate hydrogels with different concentrations
of sodium phosphate and calcium sulfate exhibits a strong trend as the time increases with an
increase in phosphate concentration and decreases with an increase in calcium concentration, as
seen in Fig. 2.2. The control hydrogels gelled immediately in various regions as the calcium
sulfate solution was added without the presence of sodium phosphate. This resulted in
inhomogeneous hydrogels. It was difficult for the remaining calcium to diffuse through the
immediately gelled sections to reach the unreacted alginate, increasing the time for complete
gelation of the whole suspension.38 Kuo et al. suggested that the use of a calcium source with
lower solubility in water allows for a more gradual gelation rate and thereby results in a more
homogeneous gel. This is because that as the calcium particles are less readily released into the
solution, they disperse more evenly throughout the medium over time before massive gelation
occurs.
Thus, Cho et al. proposed the use of a gelling agent with intermediate solubility, CaSO4,
and a retardation agent, Na2HPO4, to control the gelation rate of an alginate hydrogel.55 The
mechanism by which Na2HPO4 slows down the gelation of alginate is through a chemical
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reaction with CaSO4, resulting in the formation of calcium phosphate. Due to the sparing
solubility of CaSO4, calcium ions are made available in solution over time. As the calcium is
released through the suspension as ions, a high concentration of phosphate ions will quickly react
with them to form calcium phosphate precipitates. This precipitation leaves less calcium
available in solution for the immediate gelation of alginate. During this period, the rest of the
CaSO4 has more time to disperse throughout the alginate suspension. Thus, once all of the
phosphate ions have precipitated with calcium ions, the calcium is then made available to
crosslink the alginate G blocks via formation of the egg box structure uniformly throughout the
suspension. Therefore, the order of stability of calcium in the composite and thus order of
formation can be inferred to be calcium phosphate as the most stable, followed by calcium
alginate and finally calcium sulfate.126 The precipitation mechanism is an advantageous addition
to the system to help control the gelation rate but the solubility of the calcium source plays a
more dominate role. If a retardation agent is used with a highly soluble source, inhomogeneous
gelation would still occur because the calcium ions would not be evenly distributed throughout
the suspension. Only a combination of the two approaches can result in the greatest control of the
gelation rate of the alginate as well as the homogeneity of the resulting hydrogel.
Our data shows that the rate of gelation does in fact decrease with increasing phosphate
and decreasing calcium concentrations (and vice versa) for an unchanged concentration of
alginate, corroborating previous studies.55,126 An increase in calcium concentration at a constant
concentration of phosphate decreases the gelation time as more calcium ions are made available
to participate in the crosslinking with the G blocks of the alginate. This also results in an increase
in the ultimate hydrogel strength.118 A lower phosphate concentration will allow the sol–gel
transition to occur more rapidly as the calcium phosphate precipitation will be completed more
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quickly. The result is a decrease in the homogeneity of the hydrogel and thus its mechanical
properties.126 This was also confirmed by our data as the inhomogeneous controls (without
phosphate) exhibited the lowest compressive moduli.
Although the reported compressive moduli of the alginate hydrogels are relatively weak,
the results are within the same order of magnitude (kPa) as those of alginate hydrogels reported
previously.38,57,126,128 A–P-9 hydrogels (0.40 (w/v%) Ca–0.12 (w/v%) P) exhibited the greatest
compressive modulus among tested hydrogels of various calcium and phosphate compositions.
This can be attributed to a greater number of alginate–calcium bonds formed at a higher calcium
concentration. As previously mentioned, the highest phosphate concentration postponed the
gelation process via precipitation with calcium ions. This allowed for controlled diffusion of the
remaining calcium throughout the alginate before the ions contributed to gelation, which resulted
in uniform hydrogels.
The addition of various weight percentages of pure collagen fibers did not significantly
affect the gelation time of the alginate hydrogels. Also, the differences in time were not
statistically significant from that of the control. However, the compressive moduli of the
hydrogels with 2.5, 5 and 10 weight percent pure collagen fibers did significantly increase
compared to the control (A–P-9). This can be attributed to the composite rule of mixtures which
explains that the mechanical strength of a composite is in between those of the continuous,
matrix phase and reinforcement phase.129 As the compressive modulus of collagen fibers is
greater than that of alginate, it is reasonable that the average compressive modulus of A–C
hydrogels is greater than that of A–P hydrogels.
Fig. 2.4 shows that the average gelation times of A–MC-1a and A–MC-1b hydrogels with
2.5% (w/v) and 5% (w/v) mineralized collagen fibers, respectively, were shorter than that of the
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control and the differences in times were statistically significant. The average gelation times
were also significantly shorter than that of hydrogels with 2.5% (w/v) pure collagen fibers. This
eludes to the fact that the mineralized fibers have an impact on the gelation rate of the alginate
hydrogels.
Kikuchi et al. explain that the in situ formation of hydroxyapatite onto collagen fibers is
initiated by the nucleation of calcium ions onto the carboxyl groups of the collagen fibers.108,109
The calcium ions then bind to the phosphate ions added to the collagen solution, forming
hydroxyapatite. This in situ nucleation process has been adapted in our m-SBF method to form
apatite onto our collagen fibers (mineralized collagen fibers) before alginate addition. The
particles deposited onto the collagen fibers are apparent in Fig. 2.3. This apatite precipitation
technique has been extensively researched in our lab and hydroxyapatite formation onto collagen
hydrogel fibers has been confirmed using various characterization analyses in previous
studies.111,112 Tampieri et al. have indicated that apatite particles could provide calcium ions
capable of crosslinking alginate chains.125 Lu et al. also suggested that in situ, calcium ions are
released from apatite particles to aid in alginate gelation.128 Thus, it is hypothesized that the
apatite nucleated onto our collagen fibers can also release calcium ions into
solution. The released calcium is then available to bind to the deprotonated carboxyl groups of
the alginate chains, resulting in premature partial crosslinking. In other words, the crosslinking of
alginate G blocks occurred before the addition of CaSO4. The proposed process is depicted in
Fig. 2.10.
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Figure 2.10: Schematic of the hypothesized "pre-mature" alginate crosslinking mechanism

The proposed partial crosslinking of alginate chains before the addition of CaSO4 is
supported by the observed increase in viscosity and gelation rate of the alginate suspension with
mineralized collagen fibers (A–MC-1) when compared to the pure alginate suspension. This also
provides an explanation as to why the addition of pure collagen fibers to the alginate suspension
resulted in a significant increase in compressive modulus while the addition of mineralized
collagen fibers in A–MC-1 hydrogels did not. Because the pure collagen fibers are not hindering
the binding of the G blocks to the calcium, they are able to serve as reinforcements.
To further investigate the hypothesis that premature alginate crosslinking occurred, the
order in which the constituents were added to form the hydrogel was modified so that the
phosphate solution was added before the alginate powder (A–MC-2). Thus, any calcium released
from the mineralized collagen fibers would precipitate with the phosphate ions to form calcium
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phosphate, which would prevent premature partial gelation of the alginate. This is supported by
our experimental data as an increase in gelation time of the A–MC-2 hydrogels compared to that
of A–MC-1 hydrogels was observed. Therefore, the calcium ions had more time to disperse
throughout the suspension before gelation occurred, resulting in a more controlled, uniform
gelation process. As previously explained, hydrogels with more homogeneous material
properties demonstrate higher mechanical properties than inhomogeneous hydrogels. This was
exhibited by the A–MC-2 hydrogels which had the strongest compressive modulus out of all of
the hydrogel samples studied. It is proposed that this is because the G block-calcium crosslinks
were no longer disrupted by the mineralized collagen fibers and the fibers were able to serve as
reinforcements in the alginate matrix.
The order in which the phosphate is added to the system plays a crucial role in the
resulting material properties. By modifying the order of phosphate addition, the 2.5 % (w/v) A–
MC-2 demonstrates the highest compressive modulus and appropriate gelation time. As such, it
was identified as the most promising candidate as an injectable hydrogel for bone tissue
engineering. The A–MC-2 gelation time is within the time defined as an ‘‘ideal surgical time’’ of
5–30 minutes and its compressive modulus is deemed sufficient for the proposed non-load
bearing applications. These may include maxillofacial reconstruction or reinforcement purposes
such as filling bone micro-fractures or osteoporotic bone to simply increase the rate of
healing.106,113,130,131 Injection of the hydrogel into areas of weakened bone may help restore bone
density by promoting bone growth. New bone formation induced by the hydrogel will enhance
the mechanical strength of the area and hopefully prevent further bone breakage and weakening.
Additionally, the compressive modulus of the hydrogel has the potential to be increased even
further with an increase in calcium concentration, resulting in an increase in alginate-calcium
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crosslinks. The compressive modulus would increase as long as the calcium is released slowly
and a homogeneous hydrogel is produced. Furthermore, because the biocompatibility of the
alginate hydrogel should increase substantially with the presence of mineralized collagen fibers,
it is a worthwhile addition to the system.

2.4.2 Characterization of hydrogel inorganic composition
Thermogravimetric analysis (TGA) of the hydrogel samples after heating to 900 °C
removed all of the organic components from the sample, leaving behind the inorganic residue. In
this case, the inorganic components are calcium phosphate phases and sulfate salts, proven by
XRD and FTIR analyses. The addition of phosphate to A–Ca hydrogels resulted in a statistically
significant increase in weight percent residue. The addition of pure collagen to the A–P
hydrogels did not significantly affect the weight percent residue after 900 °C as the same amount
of salts are present in the composition of both A–P and A–C hydrogels. The percent residue also
does not significantly change with the addition of mineralized collagen fibers (A–MC-1) to the
A–P hydrogels. However, when phosphate was added before alginate to prevent premature
gelation (A–MC-2), a significant increase in percent residue was observed. This could be
attributed to the fact that an increase in calcium ions took part in the formation of calcium
phosphates in A–MC-2 compared to that of the A–MC-1 hydrogels. In the A–MC-1 hydrogels, a
high concentration of calcium released from mineralized collagen fibers may have accumulated
in local areas, contributing to early gelation and formation of less homogeneous hydrogels. In
contrast, the calcium ions released from mineralized collagen fibers in A–MC-2 reacted with
phosphate pre-added to the solution, which effectively prevented pre-mature gelation. As a
result, an increase in inorganic residue was observed. Thus, only remaining calcium ions from
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CaSO4 contributed to organic crosslinks with the alginate chains, forming a homogeneous
hydrogel.
XRD spectra show the change in composition of the alginate hydrogels as the result of
the addition of phosphate, pure collagen and mineralized collagen fibers. The peaks of each
hydrogel are relatively broad, indicating poorly crystalline samples. A slight shift in peaks may
be present in the A–C and A–MC spectra due to the addition of calcium phosphate phases. In the
A–C hydrogels, phosphate has the capability of nucleating onto the collagen fibers and
precipitating with calcium ions to form calcium phosphate. A–MC hydrogels have apatite
present on the collagen fibers to begin with. The interaction between alginate and calcium
phosphate may result in compression of the polymer matrix, leading to peak to shifts.132 Pure
hydroxyapatite exhibits characteristic peaks of the (211), (300) and (202) planes as three
separate, sharp peaks.133 These peaks are overlapped into a broad peak in the A–MC spectra.
This broadness of the apatite peaks can be attributed to the in situ formation of apatite,
suggesting that hydroxyapatite is nano-sized and of low crystallinity.132,134 An increase in peak
broadening is observed in the A–MC-2 spectrum due to the increase in the nano-sized inorganic
components in the hydrogel. However, these characteristics closely resemble that of natural
bone, making this composition suitable as a bone substitute.105
FTIR spectra of the various alginate hydrogels show that the main alginate carboxyl
absorption bands are present in each sample yet are not in the same exact location for each type
of hydrogel. The addition of phosphate to A–Ca hydrogels results in the shifting of these bands
at 1595 cm-1 and 1410 cm-1 to higher wavelengths, also known as a blue shift. This suggests an
interaction between the alginate and the calcium phosphate formed. The shifts in the PO43- group
bending and O–H stretching bands also confirm the interaction.122 A shift to higher wave
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numbers is also seen after the addition of pure collagen fibers. When comparing A–C and A–MC
hydrogels, a shift to a slightly lower wave number, or red shift, is seen in most absorbance bands.
As Teng et al. explained, this is indicative of an interaction between organic and inorganic
phases in the sample, supporting the idea that the in situ formed apatite crystals are in fact
bonding with the collagen and alginate components.132

2.5 Conclusions
In the work in this chapter, a novel, biocompatible injectable hydrogel for bone tissue
regeneration has been developed. The gelation time has been optimized so that the injectability
of the system is appropriate in a surgical setting, rendering a less invasive method for bone repair
compared to implantation of bone tissue engineered scaffolds. Utilizing our in situ collagen fiber
mineralization method, we were able to produce an alginate hydrogel comprised of collagen and
apatite, the two main components of natural bone, which was proven via numerous material
characterization techniques. Thus, this injectable hydrogel system contains the components
necessary to promote new bone growth and can be a promising biomaterial for
bone repair and regeneration.
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Chapter 3
Development of a novel alginate-polyvinyl alcohol-hydroxyapatite hydrogel for 3D
bioprinting bone tissue engineered scaffolds

3.1. Introduction
The practice of personalized medicine has recently shaped the progression of leading
research and innovative technology in all areas of tissue engineering. Specifically, the technique
of additive manufacturing and three-dimensional (3D) printing technology originally used in
metal processing has been applied to meet the needs of patient-specific treatment in biomedical
engineering and tissue regeneration.92,135,136 In a clinical setting, a patient's CT scan or MRI can
be used to re-construct a repaired CAD model of a damaged tissue or organ, which can then be
3D printed within 24 hours.95 Thus, a patient can receive an individualized, biocompatible tissue
with precise size and geometry in a timely fashion, alleviating reliance on organs for
transplantation which are sparsely available.137 Using this method, tissue substitutes can be
printed layer by layer to create constructs capable of promoting new tissue growth once placed in
vivo. 3D printing of various tissues and organs for regeneration, including osteochondral, bone,
skin, liver and heart valves have all been achieved in the laboratory.100,138-140 Additionally, live
cells have been successfully incorporated into hydrogel materials prior to printing and supported
by the 3D printed scaffold, in hope to enhance tissue regeneration.99,141-143
As bone is a hard tissue commonly fractured in various manners resulting in irregularly
shaped defects, the implementation of 3D printing to precisely fill these defects is of popular
interest. Common 3D printing approaches for bone tissue regeneration include powder bed
fusion and binder jetting of a ceramic particles, such as calcium phosphate phases, in hope to
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achieve scaffolds with composition and mechanical properties similar to those of natural
bone.102,144 These processes require the use of lasers or sintering, respectively, to selectively bind
particles. Although these scaffolds are often biocompatible and may promote cell proliferation in
vitro, these common processing techniques are not suitable for bioprinting, or incorporation of
cells throughout the material and subsequent printing of scaffolds with uniform cell
distribution.103 Thus, bone tissue regeneration of the defect site treated with such scaffolds most
often relies on uniform cell seeding and subsequent migration throughout the scaffold. These
processes may be difficult if the 3D printed scaffold design is intricate; posing barriers for cells
to pass by during seeding or migrate through to form a network. If cells are unable to distribute
uniformly throughout the scaffold, the defect may suffer from incomplete healing.102 Similarly,
3D printing synthetic polymers, such as PCL and PLA, have been frequently investigated for
bone tissue engineering purposes due to their exceptional printability but the high processing
temperature necessary for extrusion results in limited capability for cell encapsulation.145,146
Thus, natural biopolymer hydrogels, such as alginate and chitosan, have been recently
implemented for 3D bioprinting due to their inherent biocompatibility, high water content, and
molecular structure similar to that of the natural extracellular matrix.126,147 This renders them
easily biodegradable and favorable for cell incorporation and migration.148 Additionally, under
the right processing conditions, these biopolymers have the capacity to possess optimal
printability, or rheological properties that allow it to be extruded through a thin nozzle and
maintain a stable printed 3D structure once deposited. The selection of a hydrogel material with
both printability and biocompatibility is crucial to the success of the 3D printed scaffold applied
both in vitro and in vivo.97,149
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A widely investigated hydrogel is alginate, a natural polysaccharide derived from algae.
Its co-polymer structure is composed of consecutive units of α-L-guluronate (G-blocks) and, βD-mannuronate (M-blocks) followed by alternating MG segments.58 Alginate is unique in that it
undergoes a sol-gel transition in the presence of divalent cations such as calcium, forming an
"egg box" structure.50 Precise control over the gelation process presents alginate with ideal
properties as an optimal candidate for a biomaterial used in 3D printing.150 Moreover, alginate
possesses optimal cell encapsulation properties as the slow gelation process at room temperature
is gentle and not harmful to the cells.151 3D printed cells encapsulated in alginate have shown to
be protected from stress and pressure involved in extrusion, resulting in high viability
rates.98,152,153 Bioprinting of alginate isn't commonly implemented for bone regeneration due to
the low mechanical properties of the hydrogel compared to those of natural bone, however, it is
hypothesized that the ability to encapsulate cells throughout the scaffold may result in enhanced
regeneration.
Thus, in this chapter, 3D printing of alginate hydrogels has been thoroughly investigated
to produce biocompatible, osteoconductive scaffolds suitable for bone defect repair. Our focus
on the material rheological properties responsible for printability allowed us to develop a novel
printable material, of optimal gelation time and viscosity, capable of providing a suitable
environment for cell encapsulation. Hydroxyapatite, the main inorganic component of natural
bone, was incorporated in a polyvinyl alcohol suspension to increase the viscosity of the
hydrogel formulation, while simultaneously increasing the biocompatibility and
osteoconductivity of the printed scaffold. Additionally, mouse calvaria 3T3-E1 cells have been
incorporated in the alginate hydrogel and 3D printed to produce scaffolds of high shape fidelity
and cell viability.

49

3.2. Materials and methods
3.2.1 Preparation of hydrogel formulations
Seven hydrogel formulations of varying composition were developed and are listed in
Table 3.1. Each component was added to the same volume of deionized water across all
formulations. For formulations 1-7, alginic acid sodium salt (medium viscosity; MP Biomedicals
LLS, USA) was added to 3 mL of deionized water to form a suspension and mixed with 1 mL of
a sodium phosphate dibasic anhydrous (Na2HPO4, ≥ 99%, Fisher Scientific, USA) solution. For
formulation 6, sodium chloride (NaCl, Fisher Scientific, USA) was also added to the sodium
phosphate solution at 0.72% (w/v) of the final suspension. A suspension of hydroxyapatite (HA)
was added to formulations 3-6. Briefly, HA was prepared via a metathesis reaction.133,154 HA
powder was then added to 5 mL of a 1% (w/v) PVA (Fisher Scientific, USA) solution and mixed
on a stirring plate for 15 minutes. The HA-PVA suspension was then added to the alginatephosphate suspension and mixed until homogeneous. For all formulations, 4 mL of a calcium
sulfate anhydrous (CaSO4, 99%, Alfa Aesar, USA) solution of a final concentration defined in
Table 3.1 was then added to the suspension and mixed for 40 seconds. The suspensions were
then loaded into the HyRel extruder for 3D printing. Formulation 6 contained the total amount of
sodium ions present when formulation 5 is made with α-MEM for investigation of degradation
properties of hydrogels made for cell encapsulation studies. The control is of the same
composition as formulation 5 with the absence of the PVA-hydroxyapatite suspension so as to
investigate the role that the suspension plays on printability, cell viability and future proliferation
studies.
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Table 3.1: Final compositions of various hydrogels for 3D printing
Formulations
1) 1.5% alginate, 0.12% Na2HPO4, 0.40% CaSO4
2) 2% alginate, 0.12% Na2HPO4, 0.40% CaSO4
3) 2% alginate, 0.12% Na2HPO4, 0.40% CaSO4, 2.5% HA
4) 2% alginate, 0.12% Na2HPO4, 0.20% CaSO4, 2.5% HA
5) 2.5% alginate, 0.15% Na2HPO4, 0.20% CaSO4, 2.5% HA
6) 2.5% alginate, 0.15% Na2HPO4, 0.20% CaSO4, 2.5% HA, 0.72% NaCl
7) Control: 2.5% alginate, 0.15% Na2HPO4, 0.20% CaSO4
(*Bold font indicates difference in composition compared to previous formulation)

3.2.2 3D Printing and hydrogel printability
The HyRel System 30 3D printer with a modified EMO-25 extruder was used to conduct
3D printing of various alginate hydrogel formulations, defined in Table 3.1. Formulations were
prepared as previously described in section 3.2.1 and allowed to gelate in the extruder for 20
minutes. They were then printed using a 23 gauge needle (430 μm inner diameter) to form 7layer porous, cylindrical scaffolds with a diameter of 1.5 cm and a height of 0.2 cm.
Formulations were assessed qualitatively on the continuity of the alginate strands as extruded
through the needle in addition to the shape fidelity of the printed scaffold. Formulations that
produced continuous prints with high shape fidelity were defined as optimal and chosen for further
characterization.
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3.2.3 Rheology
To characterize the physical properties of the ideal alginate hydrogel system for 3D
printing, rheological analyses were conducted using an ARG2 rheometer (TA instruments). The
60 mm cone and plate fixture was used. To simulate the printing process, the hydrogels were
mixed until homogeneous and added directly to the rheometer. A time sweep was conducted for
20 minutes at 25 °C, a low oscillatory stress value of 1.0 Pa, and frequency of 1 Hz to obtain a
gelation profile. As formulations 5 and 6 exhibited printed scaffolds of high shape fidelity, the
recovery profile of the hydrogel after simulated extrusion was obtained. A pre-shear conditioning
step at 50.44/second was conducted for 30 seconds following the initial time sweep to simulate
extrusion during 3D printing and to break up the hydrogel. The pre-shear value was calculated using
the printing volumetric flow rate divided by the area of the needle. The recovery profile was then
obtained via a time sweep at 25 °C, an oscillatory stress of 1.0 Pa, and frequency of 1 Hz for 20
minutes. Formulation 7 was included as a control.

3.2.4 Optimal formulation characterization
The inorganic compositions of hydrogel formulations 5, 6 and 7 were analyzed using
thermogravimetric analysis (TGA) and X-ray diffraction (XRD). First, hydrogels were frozen at 25 °C and lyophilized using a freeze-dryer (Free Zone®, Labconco, USA). The inorganic weight
percent present in the hydrogels was determined using a TG analyzer (TGA-1000, Rheometric
Scientific, UK). 20 mg of the freeze-dried scaffolds were loaded into the TG analyzer and
ramped from 25 °C to 800 °C in air at a rate of 10 °C per minute. The weight loss profile was
recorded and the weight percent of the inorganic residue was calculated. X-ray diffraction (XRD,
Bruker AXS D5005) was completed to determine the composition of the hydrogels' inorganic
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components. Scans were collected over a 2-θ range of 10-50 ° at a step size of 0.02 ° and a scan
rate of 0.2 ° per minute with Cu K α radiation (k= 1.54056 nm).

3.2.5 Degradation studies in α-MEM
3.2.5.1 Diameter change
Hydrogel formulations 5, 6, and 7 (control) were chosen for investigation of degradation
properties for 14 days. For each formulation, scaffolds were printed as previously described
(n=6) and the diameters were measured using a micrometer. Printed scaffolds were then
transferred to a 100 mM CaCl2 (Calcium chloride anhydrous, Fisher Scientific, USA) bath for 1
hour for further crosslinking of the alginate chains. The diameters were measured and the
scaffolds were then added to a 24 well plate with 3 mL of alpha modified eagles medium (αMEM, Fisher Scientific, USA). On days 1, 3, 5, 7 and 14 of incubation, the media was
exchanged and a sample was chosen for diameter measurement and mechanical testing (n=3).

3.2.5.2 Dynamic mechanical analysis
Dynamic mechanical analysis (DMA) was completed using a DMA 2980 Dynamic
Mechanical Analyzer (TA instrument Inc., New Castle, DE) in compression mode using 40 mm
sandwich fixtures. At each previously mentioned designated time point, the diameter of the
selected printed scaffold (n=3) was measured and the print was loaded into the DMA. A preload
force of 0.01 N was applied, followed by a ramped force at a uniform stress rate of 0.5 N per
minute up to 18 N. The stress-strain curve was obtained and the compressive modulus was
calculated from the slope of the initial 20 % linear elastic region.
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3.2.6 3D bioprinting
3.2.6.1 Cell encapsulation and bioprinting
Mouse calvaria 3T3-E1 (MC3T3) cells were incorporated into the alginate hydrogel for
3D-printing. Cells were cultured in α-MEM supplemented with 10% fetal bovine serum (FBS,
Corning Cellgro, USA) and 1% penicillin-streptomycin (Fisher Scientific, USA) under an
atmosphere of 5% CO2 at 37°C. At 90% confluence, cells were harvested and re-concentrated in
the supplemented α-MEM for encapsulation.
Formulation 5 was chosen for bioprinting of MC3T3 cells as it was identified as having
optimal printability and rheological properties. The control was also chosen to investigate the
effect of the addition of hydroxyapatite on hydrogel printability and resulting cell viability. 5 mL
of the hydrogel formulations were prepared as previously described yet components were
suspended in sterile α-MEM cell culture media with 10% FBS and 1% penicillin-streptomycin
instead of deionized water, with the exception of the PVA solution. The volume of media to
which the components were added played a significant role in the viscosity and thus printability
of the hydrogel. Briefly, alginate powder was added to 1.5 mL of cell culture media to form a
homogeneous suspension. Na2HPO4 was added to 0.5 mL of cell culture media, which was then
mixed with the alginate suspension. HA powder was added to 1.5 mL of a sterile-filtered, 1%
(w/v) PVA solution and stirred for 15 minutes. The HA suspension was then added to the
alginate-phosphate suspension, mixed until homogeneous, and incubated in a waterbath at 37°C
while the MC3T3 cells were prepared for encapsulation. For the control formulation, alginate
was added to 2.5 mL cell culture media and Na2HPO4 was added to 1.0 mL media so that the
cells were added to a hydrogel of equi-volume with the alginate-HA formulation. 100 μL of the
MC3T3 cell suspension at a concentration of 2.5 x 105 cells/mL was added to the formulations
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and mixed gently until homogeneously suspended. The CaSO4 solution, prepared in 1.5 mL αMEM cell culture media, was then added and mixed gently to form a homogeneous suspension.
The hydrogel was transferred to the EMO-25 extruder and allowed to gelate for 20 minutes
before printing. 3D printing was then executed as previously described. Printed scaffolds were
transferred to a 2 mL of a CaCl2 bath, which was prepared by adding 0.10 g CaCl2 in 10 mL
sterile α-MEM with 10% FBS and 1% penicillin-streptomycin. The printed scaffolds were then
moved to the incubator at 37°C and 5% CO2 for 1 hour.

3.2.6.2 Assessment of cell viability
Cell viability was assessed after 3D printing and incubation in the calcium bath to ensure
the procedure was not harmful to the cells. To assess the viability of cells encapsulated in the
optimal alginate-PVA-HA and the control formulations (n=10 each) directly after printing, 0.80
mL of a 0.10 M sodium citrate solution was added to the printed scaffold in a 1.5 mL centrifuge tube
and incubated for 1 hour to dissociate the alginate-calcium bonds. Aliquots were then taken from the
suspension, mixed 1:1 with Trypan Blue solution (0.4 %, Sigma Aldrich, USA), and cells were
counted under the light microscope using a hemacytometer. The number of cells throughout the
suspension was calculated and the viability was determined as a percent of the cells seeded. As prints
were approximately 0.20 mL in volume, the dilution factor incorporated in the calculation was 10. To
assess the viability after incubation in the calcium bath, optimal and control scaffolds (n=4 each)
were incubated in sodium citrate as previously described but for 2.5 hours as the increased number of
calcium-alginate crosslinks formed in the calcium bath required more time to dissociate the bonds.
Cells were counted and the viability was calculated as previously described.
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3.2.7 Statistical Analysis
Results were statistically analyzed using one-way analysis of variance (ANOVA) and
expressed as mean ± standard deviation. Statistical significance was defined as p < 0.05.

3.3 Results
3.3.1 Hydrogel printability
Hydrogel formulations were assessed on the continuity of the gel strands as extruded
through the needle as well as by the shape fidelity of the printed scaffold. Images of hydrogel
formulations 3D printed into scaffolds 1.5 cm in diameter are seen in Table 3.2. All scaffold
images are of the same magnification. Formulations 1, 2, 4 and the control were not viscous
enough to maintain separate lines, causing the lines to spread and connect which resulted in
limited porosity. These formulations also did not support consecutive, distinct layers, further
contributing to gel spreading and filling in of pores. Formulation 3 was too viscous to be
extruded continuously, which resulted in discontinuous prints with limited integration.
Formulations 5 and 6 presented optimal printability, with distinct porosity and shape fidelity.
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Table 3.2: Summary of formulation printability (Scale bar 3.75 mm)
Formulation

Reasoning

Printability

Storage
Modulus
275 Pa

1) 1.5% alginate,
0.12% Na2HPO4,
0.40% CaSO4

Initial optimal
injectable
formulation
developed in
previous studies

Not viscous enough to
maintain shape fidelity
Lines spread

2) 2% alginate,
0.12% Na2HPO4,
0.40% CaSO4

Increase viscosity

Not viscous enough to 344 Pa
maintain shape fidelity
Less spreading than 1

3) 2% alginate,
0.12% Na2HPO4,
0.40% CaSO4,
2.5% HA

Increase viscosity,
biocompatibility,
and potential
osteoconductivity

Inhomogeneous,
discontinuous flow
Too viscous
Stringy

4) 2% alginate,
0.12% Na2HPO4,
0.20% CaSO4,
2.5% HA

Decrease viscosity

Not viscous enough to 351 Pa
maintain shape fidelity

5) 2.5% alginate,
0.15% Na2HPO4,
0.20% CaSO4,
2.5% HA

Increase viscosity

Printed well
High shape fidelity

6) 2.5% alginate,
0.15% Na2HPO4,
0.20% CaSO4,
2.5% HA,
0.72% NaCl

Simulating Na+
Printed well
present in hydrogel High shape fidelity
when made with
α-MEM

7) Control
2.5% alginate,
0.15% Na2HPO4,
0.20% CaSO4

Control for cell
culture studies

Image

3572 Pa

1154 Pa

647 Pa

Not viscous enough to 42 Pa
maintain shape fidelity
Lines spread
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3.3.2 Rheology
Rheological assessments were conducted to obtain a quantifiable classification of
hydrogel printability. The storage moduli of the hydrogel formulations were determined at the
end of a 20 minute time sweep at an oscillatory stress of 1.0 Pa. This time period serves to
simulate the 20 minute gelation period that the hydrogels experience before they are 3D printed.
G' values are stated in Table 3.2 and depicted in Figure 3.1. The optimal range was determined to
be between 600-1200 Pa, exhibited by formulations 5 and 6, as lower and higher values proved
to result in prints of poor quality. Corresponding loss modulus and complex viscosity values
after the 20 minute gelation period are stated in Table 3.3.

Figure 3.1: Storage moduli profile of hydrogel formulations during 20 minute time sweep
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Table 3.3: Summary of rheological values after 20 minute gelation period
Formulation

Storage Modulus (Pa)

Loss Modulus (Pa)

|ɳ*| (Pa-s)

1

275

17

44

2

344

32

55

3

3572

150

569

4

351

29

56

5

1154

73

184

6

647

72

104

Control

42

37

9

As formulations 5 and 6 were determined to have optimal rheological properties for 3D
printing, their recovery properties were investigated. Formulation 7 was included as a control. A
pre-shear conditioning step at 50.44/s was conducted for 30 seconds following the initial time
sweep to simulate extrusion during 3D printing and to break up the hydrogel crosslinks. The
recovery profile was then obtained via a time sweep for 20 minutes at a low oscillatory stress of
1.0 Pa, depicted in Figure 3.2.
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Figure 3.2: Recovery profile of select formulations after applied pre-shear, time period defied by
dotted lines

3.3.3 Optimal formulation characterization
The X-ray diffraction patterns of optimal hydrogel formulations 5 and 6 and the control
formulation 7 are shown in Figure 3.3. Optimal formulations exhibited characteristic peaks of
hydroxyapatite including those at 25.6°, 31.6°, 32.3°, 33.8° and 39.1°, depicted in pattern c).
Formulation 6 exhibits an additional peak at 45.2° due to the presence of NaCl. As expected, the
control lacked any major crystalline peaks due to its mainly organic composition.
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Figure 3.3: XRD patterns of a) formulation 5, b) formulation 6, c) hydroxyapatite and d) control
(*) indicates major additional NaCl peak

Thermogravimetric profiles of optimal hydrogel formulations 5, 6 and the control are
shown in Figure 3.4. An increase in inorganic content compared to that of the control was
observed in formulations 5 and 6. The weight percent of the residue of formulation 5 was
determined to be 54.4% while that of formulation 6 was determined to be 56.6%. Formulation 6
had a slightly higher percent residue due to the presence of NaCl. The control had a much lower
percent residue at 30.7% due to the lack of hydroxyapatite incorporated into the hydrogel.
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Figure 3.4: TGA curves of a) control, b) formulation 5 and c) formulation 6

3.3.4 Degradation studies in α-MEM
3.3.4.1 Diameter change
Degradation properties of formulations 5 and 6 in α-MEM were investigated to determine
the potential of the hydrogels to maintain integrity over 14 days. The control was included to
compare degradation properties of optimal hydrogels with those of a formulation lacking
hydroxyapatite, which is hypothesized to have an effect on cell viability in in vitro cultures.
Figure 3.5 shows that after immersion in the calcium bath for 1 hour, scaffolds composed of
formulations 5 and 6 shrunk in diameter by 23.5% and 24.9% respectively, due to further
crosslinking of the alginate chains. Swelling values were calculated compared to the scaffold
diameter measured after immersion in the calcium bath. After incubation in α-MEM for 14 days,
formulation 5 scaffolds exhibited increased swelling up to 32.7%. Similarly, formulation 6
scaffolds exhibited increased swelling up to 33.0% after 14 days. The only statistical significant
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difference between formulation 5 and 6 was observed after 1 day of incubation. The control
scaffolds exhibited different degradation properties throughout the study due to the difference in
initial morphology of the printed scaffolds. After incubation in the calcium bath, control
hydrogels only shrunk on average by 2.8%, which is statistically significantly different from the
shrinkage exhibited by formulation 5 and 6 scaffolds. Additionally, the control continued to
shrink on day 1 by 4.3% whereas formulations 5 and 6 exhibited significant swelling. After
incubation for 14 days, the control scaffolds only swelled up to 3.3%. These values are also
statistically significantly different from those of formulations 5 and 6 at each time point.

Figure 3.5: Diameter change of select scaffold formulations at various time points throughout
degradation study (p < 0.05, ANOVA, n = 3)
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3.3.4.2 Dynamic mechanical analysis
The compressive moduli of 3D printed formulations 5, 6, and the control were also
determined after incubation in the calcium bath and on days 1, 3, 5, 7 and 14 in α-MEM. Figure
3.6 shows a continuous decrease in the compressive moduli of both formulation 5 and 6 scaffolds
over 14 days. The average compressive modulus for formulation 5 scaffolds was determined to
be 10.3 kPa after immersion in the calcium bath and continually decreased over 14 days to a
value of 2.4 kPa. Similarly, formulation 6 scaffolds exhibited an average compressive modulus
of 8.6 kPa after immersion in the calcium bath and continually decreased to 2.8 kPa after 14
days. The control scaffolds exhibited limited change in compressive modulus throughout the 14
days starting at 4.7 kPa after the calcium bath and decreasing to 2.7 kPa after incubation for 14
days.

Figure 3.6: Compressive moduli of select scaffold formulations throughout degradation study (p
< 0.05, ANOVA, n = 3)
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3.3.5 Bioprinting and viability of encapsulated MC3T3 cells
MC3T3-E1 cells were successfully encapsulated into the control and optimal alginatePVA-HA hydrogel formulations and 3D printed into scaffolds with a diameter of 1.5 cm.
Compared to the control, the alginate-HA scaffolds have significantly higher shape fidelity,
shown in Figure 3.7.

Figure 3.7: Images of 3D bioprinted a) control and b) optimal alginate-polyvinyl alcoholhydroxyapatite hydrogel formulations embedded with MC3T3-E1 cells (Scale bar 3.75 mm)

Cell viability analysis after 3D printing alginate-PVA-HA hydrogel scaffolds and
incubation in the calcium bath revealed average viability values of 95.6% and 77.5%,
respectively, seen in Figure 3.8. Cells encapsulated in the control formulation exhibited average
viability values of 60.1% and 22.5% after 3D printing and incubation in the calcium bath,
respectively. Cell viability was statistically significantly higher in the alginate-PVA-HA printed
scaffolds compared to the control scaffolds after both printing and incubation in the calcium
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bath. The difference in viability after incubation in the calcium bath was not significant for
alginate-PVA-HA scaffolds, but was statistically significantly lower for the control scaffolds.

Figure 3.8: Cell viability after 3D printing and incubation in the calcium bath (p < 0.05,
ANOVA, n ≥ 4)

3.4 Discussion
3.4.1 Hydrogel printability
Material selection is the most important step when applying 3D printing technology to
develop constructs intended to promote tissue regeneration. The material must be printable, or
have sufficient viscoelasticity to allow extrusion through a small needle followed by recovery,
while also being biocompatible and not eliciting an adverse immune response. Furthermore, it is
of great interest that the material has the capability to encapsulate and support live cells
throughout the printing process. For bone tissue engineering, the development of a hydrogel
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material capable of 3D bioprinting scaffolds of uniform cell distribution has potential to promote
enhanced healing compared to conventional scaffolds for bone regeneration. Alginate is a perfect
candidate for 3D bioprinting due to its controllable gelation process and natural hydrogel
structure, similar to that of the native extracellular matrix.
The gelation mechanism of alginate has been thoroughly investigated and is such that
divalent cations, such as calcium, form intermolecular bonds with two deprotonated carboxylate
groups of one alginate G block and two hydroxyl groups of another.120 Alginate undergoes a solgel transition as a result of crosslinking of lateral "egg box" multimers.114 The rate of this
gelation process can be controlled by adjusting the concentration of both alginate and calcium, as
well as through addition of retardation agents such as sodium dihydrogen phosphate.55 The
mechanism by which Na2HPO4 slows down the gelation of alginate is through a chemical
reaction with CaSO4, resulting in the formation of calcium phosphate. This precipitation leaves
less calcium available in solution for the immediate gelation of alginate. Thus, once all of the
phosphate ions have reacted with calcium ions, the calcium is then made available to crosslink
the alginate G blocks uniformly throughout the suspension.126 The ability to control the gelation
rate of alginate ultimately results in control of the extent of crosslinking and thus rheological
properties defining the printability of the hydrogel throughout the 3D printing process. The
inherent shear-thinning property of alginate results in a decrease in the hydrogel viscosity with
an increase in shear rate.47 Thus, as the hydrogel is extruded through the needle and the shear
rate increases, the viscosity decreases to allow the hydrogel to flow more easily as continuous
strands.
Efforts to investigate printability of alginate formulations of various compositions are
summarized in Table 3.2, and correlating rheological values are listed in Table 3.3. The
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cylindrical scaffold design was chosen as a model system to determine the optimal formulations
that achieved prints of high shape fidelity. The optimal formulations will also be suitable to print
larger, more complex designs, which will be investigated in future studies. As an injectable
alginate hydrogel formulation with a gelation time defined as optimal in a surgical setting has
been developed in our laboratory, it was hypothesized that a hydrogel optimal for 3D printing
could be developed as well.155 Thus, formulation 1 was adapted from our previous studies due to
its optimal injectability. This composition served as a baseline formulation on which we
modified, based on our knowledge of alginate's gelation mechanism, to develop an ideal
formulation for 3D printing. Yet, the concentration of alginate and thus viscosity of the original
formulation was too low to maintain shape fidelity. In formulation 2, the concentration of
alginate was increased compared to formulation 1, but the hydrogel was still of low viscosity and
the resulting printed scaffold of poor quality. A polyvinyl alcohol-hydroxyapatite suspension was
added in formulation 3 to increase the viscosity of the formulation as well as to increase the
biocompatibility and osteoconductivity of the resulting scaffold. Yet, the viscosity and storage
modulus of this formulation were too high to allow sufficient yielding of the hydrogel, resulting
in discontinuous extrusion and scaffolds of poor quality. The calcium concentration was
decreased in formulation 4 in order to decrease the number of crosslinks and thus storage
modulus of the hydrogel. However, the resulting viscosity was too low to produce printed
scaffolds of high shape fidelity. An alternate approach was taken to increase the viscosity by
increasing the alginate concentration in formulation 5. The phosphate concentration was
increased concurrently to prevent premature gelation as a result of the increased number of
crosslinking sites. The slight increase in alginate concentration did result in an optimal viscosity
capable of producing 3D printed scaffolds of high shape fidelity. Thus, formulation 5 was
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defined as an optimal formulation. As the main objective of this study is to encapsulate live cells
within the hydrogel, formulation 6 simulates the composition of the hydrogel when made with
cell culture media, which is a crucial modification for bioprinting. The increased content of
sodium ions present in the cell culture media has potential to interact with the alginate gelation
process and was an important modification to investigate. As seen in Table 3.2, formulation 6
produced printed scaffolds of high shape fidelity and was deemed an optimal formulation as
well. Formulation 7 lacked the incorporation of the PVA-hydroxyapatite suspension and was
included to investigate the printability of a formulation that would serve as a control for future
cell culture studies. This formulation displayed very low viscosity and produced printed
scaffolds of very low quality with no porosity. This suggests that the presence of the PVAhydroxyapatite suspension plays a crucial role in altering the viscosity of the overall suspension
and thus resulting printability.

3.4.2 Rheology
Figure 3.1 shows the storage moduli profile of the investigated hydrogel formulations
during a 20 minute time sweep to simulate the gelation process. As seen in Table 3.3, all
formulations displayed G' values greater than G" values, signifying that all are classified as gels.
Formulations 5 and 6, which were the only formulations that resulted in 3D printed scaffolds of
high quality, expressed a storage modulus value between 600-1200 Pa after the gelation period.
The storage modulus value can be correlated to the physical printability observed as the
formulations were elastic enough to allow continuous extrusion through the 430 μm needle and
recovery upon deposition, while viscous enough to maintain shape fidelity once printed.
Formulations with G' values higher and lower than this range resulted in prints of poor quality as

69

they were either too soft to maintain high shape fidelity or too stiff to allow continuous
extrusion. This expresses the sensitivity of the gelation and viscosity of the system and the role
each constituent has on the resulting properties, thus highlighting the achievement of obtaining a
novel formulation ultimately allowing 3D bioprinting with high cell viability.
It is of the most importance that the hydrogel possesses sufficient viscoelasticy; the
property that allows the hydrogel network to deform upon extrusion but recover once deposited
so that the 3D printed layers remain distinct and produce an overall structure of high shape
fidelity.156 Figure 3.2 shows the recovery properties of the optimal and control formulations.
Following the application of a pre-shear of 50.44/s, all formulations healed and displayed
recovery of their storage modulus. The extent to which the hydrogel recovers is not of a great
concern as the scaffold is added to a calcium bath to induce further crosslinking after printing.
Thus, the shear thinning and viscoelastic properties of the alginate hydrogel formulations prevent
complete destruction of the hydrogel network. This suggests that the optimal formulations have
potential to provide a suitable environment capable of protecting cells through the extrusion
process.

3.4.3 Optimal formulation characterization
As expected, Figure 3.3 shows that optimal formulations exhibited characteristic X-ray
diffraction peaks of hydroxyapatite while the control lacked crystallinity due to its highly organic
composition. Formulation 6 exhibited an additional peak at 45.2° due to diffraction of the (220)
plane of sodium chloride. Slight peak shifting and broadening are observed due to possible in
situ formation of nano-sized, poorly crystalline hydroxyapatite and/or additional calcium
phosphate phases as a result of precipitation of calcium and phosphate ions during the gelation
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process.125,132 As hydroxyapatite is the main mineral component of natural bone, its presence
increases the osteoconductivity of the hydrogel, and thus improves the scaffolds’ potential for
bone defect repair. Additionally, including hydroxyapatite in a PVA suspension allows it to be
homogenously suspended throughout the hydrogel while simultaneously increasing the viscosity
of the hydrogel and mechanical properties and biocompatibility of the resulting scaffold.
The thermogravimetric profiles exhibited in Figure 3.4 show the quantification of
inorganic residue present in the optimal formulations 5 and 6 compared to that of the control.
Decomposition of the alginate hydrogels begins around 26 °C with the loss of water. Losses
attributed to the rupture of the alginate chains and monomers occur around 190 °C and 620 °C.
The addition of the polyvinyl alcohol-hydroxyapatite suspension in formulations 5 and 6
modifies the loss profile compared to that of the control. A significant increase in percent residue
is observed due to the presence of HA, as well as an additional loss around 450°C which can be
attributed to PVA. The loss profile of formulation 6 reveals a slight increase in percent residue
due to the presence of NaCl. As PVA is a hydrophilic polymer that has been reported to be
highly biocompatible in cell culture studies and is approved by the FDA as polymer coatings, it
contributes not only to the viscosity of the suspension but to the biocompatibility as well.55

3.4.4 Degradation studies in α-MEM
3.4.4.1 Diameter change
An investigation of the hydrogel degradation properties was conducted in order to
determine whether the 3D printed scaffolds composed of optimal formulations maintain
structural integrity and have potential to support cell life up to 14 days in α-MEM cell culture
media. The control was included to compare degradation properties of optimal hydrogels with
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those of a formulation lacking hydroxyapatite, which is hypothesized to have a positive effect on
in vitro cell viability.157 Figure 3.5 shows that after immersion in the calcium bath for 1 hour,
scaffolds composed from formulations 5 and 6 shrunk significantly in diameter. This can be
attributed to further crosslinking of alginate G blocks with the free calcium ions in the bath and
thereby compression of the alginate chains into the egg box structure.50 Formulation 6 represents
the hydrogel composition when modified for cell incorporation; specifically containing the total
amount of sodium ions present in the hydrogel when formulation 5 is made with α-MEM. This
modification was investigated to gain an understanding of degradation and swelling properties of
hydrogels made for cell encapsulation studies, as the incorporation of cell culture media is
integral for cell survival. This is specifically important as the main mechanism in which alginate
hydrogels degrade is through ion exchange between the calcium ions crosslinked with the G
blocks in the egg-box structure and the sodium ions in the surrounding media. Once the sodium
ion replaces the calcium ion in the binding site between the two G blocks, the crosslink is
destroyed as alginate does not bind with monovalent cations. This results in relaxation and
opening of the polymer G chains, permitting media to penetrate the hydrogel matrix and cause
swelling.57,158 It was important to investigate if the increased presence of sodium ions within the
hydrogel enhanced the degradation properties. Figure 3.5 shows that scaffolds of both optimal
hydrogel formulations exhibited initial significant swelling after placed in α-MEM. The
difference between the two was only significant on day 1, due to the increased ratio of nongelling ion to gelling ions in formulation 6. Thus, this suggests that a similar swelling profile will
occur over 14 days when formulation 5 is made with α-MEM for cell culture studies. It is
important that the scaffolds remained stable as a drastic increase in swelling in the presence of
cells could make it more difficult for cells to interact with each other to form a network, and
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deterioration of the alginate crosslinks could affect cell stabilization within the matrix. Swelling
stabilized after day 3 in the media, suggesting that ion exchange between the hydrogels and
surrounding media was also stabilized. As the main degradation mechanism is due to ion
exchange and is not enzymatic, this suggests that alginate hydrogels will maintain integrity in
vitro.56 The control exhibited different degradation properties due to the difference in initial
morphology and lack of porosity of the printed scaffolds. The change in diameter over the 14 day
period was minimal and statistically significantly lower than formulations 5 and 6. The lack of
porosity displayed throughout the degradation study suggests that cells encapsulated in the
control formulation in vitro may suffer from limited diffusion of nutrients and waste. Thus, the
novel specific composition of this alginate-polyvinyl alcohol-hydroxyapatite formulation is able
to produce 3D printed scaffolds with sufficient stability and potential to support cell life and
activities for 14 days in culture.

3.4.4.2 Dynamic mechanical analysis
Although the compressive moduli of the 3D printed scaffolds are relatively weak
compared to 3D printed scaffolds for bone repair reported in literature, the modulus values for
both optimal formulations after further crosslinking in the calcium bath represent scaffolds of
sufficient mechanical properties for surgical handling.151 Incubation in α-MEM resulted in a
continuous decrease in the compressive moduli of both formulation 5 and 6 scaffolds over 14
days, which is depicted in Figure 3.6. This occurrence can be correlated to the swelling of the
hydrogels due to ion exchange with the sodium ions present in the surrounding media. The
destruction of the crosslinks between the alginate G blocks and calcium ions weakens the
hydrogel structure. It has been hypothesized that the hydrogel reaches an equilibrium with the
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surrounding media around day 3, which is also corroborated by the slowing decrease in
compressive modulus at this time. As the compressive modulus decreases similarly for
formulation 5 and 6 printed scaffolds over 14 days, it is hypothesized that a hydrogel composed
of α-MEM for cell encapsulation will experience a similar decreasing compressive modulus
profile. These findings also prove the maintenance of integrity of the novel alginate-polyvinyl
alcohol-hydroxyapatite scaffolds for 14 days in cell culture, providing a stable matrix for the
cells to proliferate, mature and initiate bone regeneration. The control exhibited a less drastic
change in compressive modulus, correlating with the lack of porosity and minimal swelling
during this incubation period.

3.4.5 Bioprinting and viability of encapsulated MC3T3 cells
MC3T3-E1 cells were successfully incorporated into the optimal alginate-PVA-HA
hydrogel formulation and 3D printed into scaffolds of high shape fidelity, seen in Figure 3.7, as
neither the cell culture media nor cell suspension affects the printability of the system. Cell
encapsulation within the hydrogel matrix provides the scaffold with increased potential for tissue
healing as post-fabrication seeding processes may pose difficulties for uniform cell infiltration
and thus tissue regeneration.8 As the MC3T3 cell line is an osteoblast precursor, survival and
proliferation of the encapsulated cells throughout the scaffold provides potential to lead to new
bone deposition uniformly throughout the defect.
Viability was assessed directly after printing and after incubation in the calcium bath
separately to determine if these two processes cause damage to the encapsulated cells. After 3D
printing, it was determined that approximately 95.6% of the encapsulated cells in the optimal
alginate-PVA-HA formulation were viable, proving that the process was not harmful to the cells
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and that the hydrogel formulation was successful in providing protection. After incubation in the
calcium bath, the viability decreased to 77.5%, which may be attributed to the further
crosslinking of the alginate matrix in the presence of calcium. Such contraction of the hydrogel
matrix and shrinkage of the scaffolds, exhibited in Figure 5, has the potential to impose
additional stress on the cells and may result in cell death. However, as the viability is still
relatively high, the surviving cells still have the potential to recover and proliferate by further
incubation in vitro, which will be investigated in future studies.159 In comparison, only about
60.1% of cells were viable after 3D printing the control formulation. This can be due to the
reduced viscosity of the suspension and thus increased stress experienced by the cells during the
extrusion process, as printing parameters maintained constant throughout all formulations. Thus,
the incorporation of PVA-hydroxyapatite suspension not only increases the viscosity of the
formulation, but indirectly increases cell viability after printing as well. Furthermore, the
viability of cells encapsulated in the control formulation after incubation in the calcium bath
reduces to 22.5%. This low value can be attributed to the lack of porosity of the printed
scaffolds. Thus, when the cells are immersed in the calcium bath for an hour, they are isolated
from the nutrients provided by the surrounding cell culture media. Additionally, after incubation
in the sodium citrate solution, the printed scaffolds had to be physically broken apart to release
the cells for viability measurements. This may be due to the limited infiltration of sodium citrate
into the alginate matrix and minimal crosslink disruption as a result of the lack of scaffold
porosity. The application of physical force to the scaffold may have resulted in harm to the
encapsulated cells and caused additional cell death.
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3.5. Conclusions
In the work in this chapter, a novel alginate-polyvinyl alcohol-hydroxyapatite hydrogel
formulation with optimal rheological properties for 3D bioprinting has been developed and
employed to result in 3D printed scaffolds of high cell viability. Numerous alginate hydrogels of
varying compositions were extensively investigated to identify which concentrations possessed
viscoelastic properties allowing continuous hydrogel extrusion and sufficient recovery to
produce scaffolds of high shape fidelity. It was determined that the presence of a PVAhydroxyapatite suspension played a significant role in the viscosity and printability of the
formulations, as well as cell viability after 3D printing. 3D printed scaffolds composed of
optimal formulations displayed sufficient integrity and mechanical properties over a 14 day
incubation period in cell culture media, suggesting potential to provide a suitable environment
for cells for in vitro culture. This is supported by the ability of the optimal alginatehydroxyapatite formulation to protect cells during 3D printing and incubation in a calcium bath.
Thus, this system will be implemented further in future in vitro studies to investigate the ability
of the encapsulated MC3T3 cells to differentiate and regenerate new bone. Additionally,
scaffolds of more complex, irregular designs will be printed to assess the capability of this
optimal formulation in printing large-scale, personalized defects. Thus, bioprinting of this novel
alginate-polyvinyl alcohol-hydroxyapatite hydrogel formulation to produce scaffolds for bone
repair has the potential to provide individualized treatment of defects and promote enhanced,
uniform healing.
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Chapter 4
In vitro evaluation of 3D bioprinted tri-polymer network scaffolds for bone tissue
regeneration

4.1. Introduction
Three-dimensional (3D) printing of live cells into tissue engineered scaffolds of complex
architectures provides an alternative method to treat and heal irregular tissue defects. The
application of additive manufacturing for tissue engineering enables biomaterial scaffolds to be
constructed layer by layer into 3D replicas of repaired damaged tissues or organs for patients in
need.135,136 Although various materials have been utilized to 3D print live cells into scaffolds at
initial high cell viability, in vitro evaluations of the scaffolds’ ability to support cellular growth
and activities are necessary before implementing these scaffolds for healing in vivo.160
Polymeric hydrogel materials are often used to 3D bioprint cells into tissue engineered
scaffolds due to their inherent high water content and fibrillar structure, resembling that of the
native extracellular matrix (ECM).30,32 Both natural and synthetic polymers, including chitosan,
alginate, polyethylene glycol, polycaprolactone and many more are used to 3D print tissue
substitutes for skin, bone, liver, and other tissues and organs.89,93,141,161 It is crucial that the
material of choice possesses optimal printability as well as provides a suitable environment
mimicking that of the natural tissue to support cell life and promote innate physiological
behaviors.97,162 The natural bone environment includes inorganic hydroxyapatite (HA) minerals
and organic collagen fibers, which is also the major structural component in the ECM.92
Conventional methods for 3D printing scaffolds for bone tissue engineering often use ceramic
materials composed of HA and limit the inclusion of live cells throughout the fabrication

77

process.16,163 3D bioprinting live cells with a hydrogel is a favorable approach to supply a
homogeneous cell population throughout the scaffolds to promote enhanced homogeneous
healing.
The environment in which cells live plays a vital role in the physiological morphology
and behavior they express in in vitro culture.79,164 For example, they must be provided with
proper attachment sites to form integrin binding complexes to the matrix. The integrin receptors
on the cell cytoskeleton have an affinity for complexes such as ligands and RGD modalities in
which they will attach to.80,86 They will then begin to exhibit stretched morphology favorable for
cell migration as opposed to rounded morphology expressed by cells experiencing improper
attachment to the matrix.165,166 Additionally, the mechanical properties of the scaffolds must be
appropriate to support cell proliferation and provide stability to counter cellular contractile forces
imposed during migration throughout the matrix.167,168 Lawyer et al. reported that the stiffness of
the scaffolds greatly impacts the migration and proliferation abilities of the cells in the
scaffold.169 Thus, it has been concluded that a synergistic effect exists between the biological and
mechanical properties of the scaffold which plays a significant role in determining the
physiological behavior of the encapsulated cells. These properties must be investigated and
understood before the scaffold can be implemented in vivo.
Thus, in the work in this chapter we initially evaluated the ability of our previously
developed novel alginate-polyvinyl alcohol (PVA)-HA hydrogel formulation and to support
cellular life and functions in in vitro culture.170 We have 3D printed pre-osteoblastic MC3T3
cells into scaffolds for bone tissue regeneration and assessed the proliferation of these cells
encapsulated within the scaffolds. A systematic approach was taken to improve the proliferation
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within the scaffolds, eventually leading to the development of a novel tri-polymer formulation
with the addition of collagen hydrogel.

4.2. Materials and methods
4.2.1 Preparation of hydrogel-cell suspension
Mouse calvaria 3T3-E1 cells were encapsulated in the alginate-PVA-HA hydrogel for 3D
printing. Cells were cultured in alpha modified eagles medium (α-MEM, Fisher Scientific)
supplemented with 10% fetal bovine serum (FBS, Corning Cellgro) and 1% penicillinstreptomycin (Fisher Scientific) under an atmosphere of 5 % CO2 at 37 °C. At 90 % confluence,
cells were harvested and re-concentrated in the supplemented α-MEM for encapsulation.
An alginate-polyvinyl alcohol-hydroxyapatite formulation developed previously in our
laboratory was used for 3D bioprinting of honeycomb and alternating rectilinear scaffold
designs.170 Briefly, alginic acid sodium salt (medium viscosity; MP Biomedicals LLC) was
added to sterile supplemented α-MEM at 2.5% (w/v) of the final suspension and mixed with a
sodium phosphate dibasic anhydrous (Na2HPO4, ≥ 99%, Fisher Scientific) solution in
supplemented α-MEM at 0.15 % (w/v) of the final suspension. Hydroxyapatite (HA) was
prepared via a metathesis reaction.154 HA powder was then added at 2.5 % (w/v) of the final
suspension to a sterile-filtered 1 % (w/v) polyvinyl alcohol (PVA, Fisher Scientific) solution and
mixed on a stirring plate for 15 minutes. The HA-PVA suspension was added to the alginatephosphate suspension, mixed until homogeneous, and incubated in a waterbath at 37 °C while the
MC3T3 cells were prepared for encapsulation. 100 μL of the MC3T3 cell suspension at a final
concentration of 1.0 x 106 cells/mL was added to the formulation and mixed gently until
homogeneously suspended. A calcium sulfate anhydrous (CaSO4, 99%, Alfa Aesar) solution in
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supplemented α-MEM at 0.20% (w/v) of the final suspension was then added and mixed for 40
seconds to initiate gelation. The hydrogel was transferred to the EMO-25 extruder and allowed to
gelate for 30 minutes before 3D printing. A control formulation of the same concentrations but
without incorporation of the PVA-HA suspension was included to investigate the effect of the
presence of hydroxyapatite in 3D printed scaffolds on cell proliferation. For the control
formulation, the volumes of the alginate suspension and Na2HPO4 solution were increased so that
the cells were added to a hydrogel of equi-volume with the alginate-HA formulation. Hydrogel
preparation was conducted as previously described.

4.2.2 3D bioprinting
The HyRel System 30 3D printer with a modified EMO-25 extruder was used to conduct
3D bioprinting of MC3T3 cells encapsulated in an alginate-PVA-HA hydrogel. After gelating for
30 minutes in the extruder, 3D printing was initiated and the hydrogel-cell suspension was
extruded through a 23 gauge, 430 μm needle into pre-determined scaffold designs. The computer
software programs Repetrel and Slic3r were used to construct a G-code file to print a 1.5 cm
cylindrical scaffold with a honeycomb infill pattern at a 40% infill density. The control
formulation was also printed according to this design. To determine if a different infill design
would have an effect on cell proliferation, an alternating rectilinear G-code file was created in
which every two layers were rotated 45°. All other parameters remained constant. After printing
was complete, scaffolds were transferred to a 1.0 % (w/v) CaCl2 (Calcium chloride anhydrous,
Fisher Scientific) bath in α-MEM for 1 hour in the incubator at 5 % CO2 and 37 °C for further
crosslinking of the alginate chains. Crosslinked scaffolds were then added to a 24 well plate with
1 mL of fresh α-MEM and returned to the incubator. Media was refreshed every other day during
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the entire period of in vitro studies. A schematic of the 3D bioprinting process can be seen in
Figure 4.1.

Figure 4.1: Schematic of 3D bioprinting process

4.2.3 In vitro proliferation
The proliferation of MC3T3 cells encapsulated in 3D printed alginate hydrogels over 10
days was assessed using an alamarBlue assay (Fisher Scientific). Healthy cells metabolize the
dye and reduce resazurin to the fluorescent molecule, resorufin. The extent of reduction can be
quantified via spectroscopy and directly correlates with the number of healthy, metabolically
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active cells present in the scaffolds. An increase in reduction thereby signifies an increase in cell
number and thus proliferation. At select time points, 3D printed scaffolds were chosen for
analysis and incubated in 0.1 M sodium citrate (Fisher Scientific) solution in a 1.5 mL centrifuge
tube for 1 hour to dissociate the alginate-calcium bonds. The suspensions were then centrifuged at
1400 rpm for 5 minutes to form a cell pellet. The media was removed and 1 mL of fresh media and

100 μL of alamarBlue dye were added to the centrifuge tube, which was then incubated at an
atmosphere of 5 % CO2 at 37 °C for 4 hours. 200 μL aliquots were then added to a 96 well plate
and the absorbance was read using a spectrometer (Biotek, USA) at 570 nm and a reference
wavelength of 600 nm. The reduction of the alamarBlue was then calculated according to the
equation provided by the manufacturer.

4.2.4 Effects of calcium bath
In efforts to increase the proliferation of the MC3T3 cells in the 3D printed scaffolds of
original and alternating infill designs, the concentration of the calcium bath was decreased to 0.5
% (w/v) CaCl2.

4.2.4.1 Diffusion properties of 3D printed scaffolds
To investigate the diffusion properties of the 3D printed hydrogel scaffolds, fluorescein
isothiocyanate (FITC)-dextran (40kDa, Fisher Scientific) was added to the hydrogel formulations
before the addition of CaSO4 at a final concentration of 0.084 mg/mL. Dextran was incorporated
to serve as a model molecule to obtain insight on the diffusion properties of nutrients and waste
through the scaffolds, as it is a small polysaccharide. Scaffolds of the original and alternating
infill designs and the control formulation were 3D printed and crosslinked with either 0.5 %
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(w/v) or 1.0 % (w/v) CaCl2 (n=4 each) for 1 hour. The scaffolds were then added to a 24 well
plate and incubated with 1 mL of α-MEM in a waterbath at 37 °C. To obtain a release profile,
aliquots were taken and read with a fluorescent plate reader (excitation:490 nm, emission:520
nm) with media replenished at 2 hours and refreshed every 24 hours. Permeability coefficients
were calculated using FITC-dextran flux from the linear region of the release profile. Diffusion
coefficients were calculated using scaffold thickness of 0.15 cm and partition coefficient k=1.0.

4.2.4.2 Calcium cytotoxicity analysis
MC3T3 cells were grown and cultured as previously described for investigation of the
effect of the calcium bath on cellular proliferation. Cells were seeded at a concentration of 2.0 x
105 cells/mL in 24 well plates and allowed to attach for 4 hours. They were then introduced to a
0 %, 0.5 % (w/v) or 1.0 % (w/v) CaCl2 solution in α-MEM (n=3 each) for 30 minutes, simulating
scaffold incubation in the calcium bath. Cells were then rinsed with 1 x PBS solution, and 1 mL
of fresh α-MEM was added to each well before incubation at 37 °C and 5 % CO2 atmosphere.
Proliferation analyses were conducted as previously described.

4.2.5 Addition of collagen content
Type I collagen was extracted from rat tails and dissolved in 0.02 M acetic acid, resulting
in a collagen solution with a concentration of 5.6 mg/mL.111,127,171 To form a collagen gel, the pH
of 5 mL of this solution was raised to 7 using sodium hydroxide and incubated overnight in a
waterbath at 37 °C. The precipitates were collected via filtration and air dried for 20 minutes.
The hydrogel formulation used for 3D bioprinting was prepared as previously described with 5.0
% (w/v) of the wet collagen gel added to the alginate-phosphate suspension and mixed
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homogeneously before the addition of the PVA-HA suspension. Gelation, 3D printing, and
proliferation analyses were then conducted as previously described.
As an alternative method to increase proliferation and limit damage inflicted on the cells
due to the presence of calcium, the duration of the calcium bath was decreased to 30 minutes for
both 0.5 % (w/v) and 1.0 % (w/v) CaCl2 concentrations. Additionally, scaffolds were rinsed in 1x
phosphate buffer saline (PBS) for 30 seconds to remove excess calcium from the scaffolds before
incubation in fresh cell culture media. Proliferation analyses were then conducted as previously
described.
In final efforts to increase proliferation, the collagen content was increased to 6.5 %
(w/v). Scaffolds were 3D printed, added to the calcium bath, rinsed with 1 x PBS, and
proliferation analyses were conducted as previously described.

4.2.6 Mechanical properties
To investigate the mechanical properties of scaffolds composed of the alginate-PVA-HAincreased collagen (6.5 % (w/v)) formulation, scaffolds were 3D printed as previously described
and incubated in either 0.5 % (w/v) or 1.0 % (w/v) CaCl2 for 30 minutes. Scaffolds were rinsed
with 1x PBS after which the diameters were measured with a micrometer. Scaffolds were then
transferred to a 24 well plate, incubated with 1 mL of α-MEM supplemented with 1 % (w/v)
penicillin. They were then incubated in a waterbath at 37 °C for 10 days, with the media
exchanged every other day.
Dynamic mechanical analysis (DMA) was completed using a DMA 2980 Dynamic
Mechanical Analyzer (T.A. Instrument Inc., New Castle, DE) in compression mode. Scaffold
diameters were measured before loading onto the 40 mm sandwich fixtures. A uniform stress
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rate of 0.5 N per minute was ramped from 0 to 18 N. The stress-strain curve was obtained and
the compressive modulus was calculated from the slope of the linear elastic region within the
initial 15% strain.

4.2.7 Statistical analysis
Results were statistically analyzed using one-way analysis of variance (ANOVA) and
expressed as mean ± standard deviation. Statistical significance was defined as p < 0.05.

4.3 Results
4.3.1 3D printing of scaffolds with different infill geometries
Scaffolds of original and alternating infill geometries were 3D printed and are shown in
Figure 4.2a and 4.2b, respectively. The control formulation, shown in Figure 4.2c, was unable to
produce scaffolds of high shape fidelity and thus lacked the macroporosity achieved by the
alginate-PVA-HA formulation. All scaffolds are 1.5 cm in diameter.

Figure 4.2: 3D printed a) original design b) alternating design and c) control scaffolds (Scale bar
3.75 mm)
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4.3.2 Evaluation of proliferation
4.3.2.1 Infill geometry
Cellular reduction of alamarBlue and thus cell number over 10 days showed little to no
proliferation of MC3T3 cells in any of the 3D bioprinted scaffolds, as shown in Figure 4.3. No
statistical differences in cellular reduction were observed between scaffolds of original and
alternating infill designs. A slight increase in reduction was observed for scaffolds of original
and alternating designs from day 1 to day 4, whereas a decrease in reduction was seen in control
scaffolds during the same time period.

Figure 4.3: Proliferation of cells in 3D bioprinted scaffolds after 1 % (w/v) CaCl2 bath (p < 0.05,
ANOVA, n ≥ 3)
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4.3.2.2 Effects of calcium bath
The decrease in calcium concentration of the calcium bath from 1.0 % to 0.5 % (w/v)
CaCl2 for bioprinted scaffolds of original and alternating infill designs resulted in a slight
increase in cellular reduction of alamarBlue on day 1, but no further increase in cell number was
observed over 7 days, as seen in Figure 4.4. A slight decrease in reduction and thus cell number
was observed on day 7 for both scaffold types.

Figure 4.4: Proliferation of 3D bioprinted scaffolds after 0.5 % (w/v) CaCl2 bath (p < 0.05,
ANOVA, n = 2)
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4.3.2.2.2 Calcium cytotoxicity analysis
Figure 4.5 shows the reduction of alamarBlue by MC3T3 cells with or without incubation
in a calcium bath. After exposure to calcium for 30 minutes, cells incubated in 0.5 % and 1.0 %
CaCl2 exhibited 6.1 % and 7.3 % less reduction, respectively, compared to the control in which
cells were not exposed to calcium. The difference in reduction from the control was only
statistically significant for cells in scaffolds incubated in 1.0 % CaCl2 baths.

Figure 4.5: Cytotoxic study of MC3T3 cells incubated in calcium baths of various concentrations
(p < 0.05, ANOVA, n = 3)

4.3.2.2.3 Scaffold diffusion properties
The cumulative release profile of FITC-dextran from the 3D printed scaffolds after
incubation in the calcium bath is shown in Figure 4.6a. Dextran was incorporated to serve as a
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model molecule and obtain insight on the diffusion properties of nutrients and waste through the
scaffolds. Figure 4.6a shows the release profile over 3 days, while Figure 4.6b shows a zoomed
in profile of the first 1.5 hours of incubation in fresh cell culture media. Release from the
scaffolds during incubation in the calcium bath was difficult to accurately quantify and was thus
not included as the precipitated calcium present in the aliquots interfered with the fluorescent
readings and all values were amplified. During incubation in fresh cell culture media for three
days, approximately 11, 8, and 5 μg of FITC-dextran were released from the control, original and
alternating design scaffolds incubated in 1.0 % (w/v) CaCl2, respectively. Approximately 14, 10
and 6 μg of FITC-dextran were released from control, original and alternating design scaffolds
incubated in 0.5 % (w/v) CaCl2, respectively.
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Figure 4.6: a) Cumulative release profile of FITC-dextran from scaffolds with control (C),
original (O) and alternating (A) infill designs incubated in 0.5 % or 1.0 % CaCl2 b) Magnified
release profiles of 1.5-3 hours

Figure 4.7 shows the permeability coefficient of FITC-dextran released from each
scaffold type incubated in both 0.5 % and 1.0 % (w/v) CaCl2 baths, calculated from the release
profile from 1.5 to 3 hours. For each infill design, scaffolds incubated in 0.5 % (w/v) CaCl2 baths
expressed greater permeability than those incubated in 1.0 % (w/v) CaCl2 baths. Scaffolds of the
original infill design displayed the greatest permeability values. Diffusion coefficients were
calculated and are listed in Table 4.1.
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Figure 4.7: Permeability coefficients of FITC-dextran released from 3D printed scaffolds (p <
0.05, ANOVA, n = 3)

91

Table 4.1: Diffusion coefficients of FITC-dextran from 3D printed scaffolds
Infill geometry

Diffusion Coefficient (cm2/s)
0.5 % (w/v) CaCl2

1.0 % (w/v) CaCl2

Control

7.31E-07

3.97E-07

Original

1.49E-06

1.06E-06

Alternating

6.80E-07

5.59E-07

4.3.2.3 Effect of collagen content
Reduction of alamarBlue by cells 3D bioprinted into scaffolds with 5.0 % (w/v) collagen
under various conditions can be seen in Figure 4.8a. Cells 3D printed into collagen containing
scaffolds incubated under all conditions exhibited greater reduction on day 1 compared to cells
printed in scaffolds without collagen. A significant change in cell number was not observed over
10 days for prints incubated in the 0.5 % (w/v) CaCl2 bath for 1 hour. When the duration of the
calcium bath was decreased to 30 minutes and a 1x PBS rinsing step was added, a significant
increase in reduction was observed on day 1, however, no significant increase in reduction was
observed over 10 days. Scaffolds incubated in 1.0 % (w/v) CaCl2 baths for 30 minutes exhibited
lower reduction on day 1 followed by a slight increase in reduction until day 7 and a decrease on
day 10. The addition of a 1x PBS rinsing step resulted in a slight increase in reduction over 10
days.
Figure 4.8b shows cellular reduction of alamarBlue in scaffolds printed with increased
collagen content. When the collagen content was increased to 6.5 % (w/v), printed scaffolds
incubated in 0.5 % (w/v) CaCl2 for 30 minutes showed comparable reduction to prints with 5.0
% (w/v) collagen for the duration of the study, with a slight decrease in reduction observed on
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day 7 but an increase on day 10. Cells printed in scaffolds with 6.5 % (w/v) collagen and
incubated in a 1.0 % (w/v) CaCl2 bath showed significantly higher reduction at each time point.
Additionally, an increase in reduction was observed until day 7 in culture, followed by a slight
decrease in reduction on day 10.
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Figure 4.8: AlamarBlue reduction by cells 3D printed into scaffolds with a) 5.0 % (w/v) and b)
6.5 % (w/v) collagen incubated in 0.5 % (w/v) and 1.0 % (w/v) CaCl2 baths (p < 0.05, ANOVA,
n = 2)

4.3.3 Mechanical properties
The compressive moduli of 3D printed scaffolds with increased collagen content (6.5%
(w/v)) incubated in a 0.5 % or 1.0 % (w/v) CaCl2 bath for 10 days in in vitro culture conditions
are shown in Figure 4.9. Initially after 1 day in culture, scaffolds incubated in 1.0 % (w/v) and
0.5 % (w/v) CaCl2 had average compressive modulus values of 9.5 kPa and 8.0 kPa, respectively.
Scaffolds incubated in both calcium bath concentrations displayed a statistically significant
decrease in compressive moduli on day 4 but did not continue to significantly decrease for the
duration of the study. After day 1, scaffolds incubated in 1.0 % CaCl2 continued to display
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higher compressive moduli values than those incubated in 0.5% CaCl2 for the duration of the
study, although only statistically significant on day 7.

Figure 4.9: Compressive moduli of increased collagen scaffolds throughout degradation study (p
< 0.05, ANOVA, n = 2)

4.4 Discussion
4.4.1 Proliferation
As we previously identified an optimal hydrogel formulation capable of 3D bioprinting
scaffolds of high shape fidelity and initial cell viability, it was important to further investigate the
capability of the hydrogel scaffolds to support long-term cellular life and activities. Before cells
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can differentiate and begin to form new tissue, it is crucial that they form a cellular network
within the hydrogel matrix and begin to migrate and proliferate.172 In order to follow the natural
progression of processes resulting in tissue formation, there must first exist cell adhesion ligands
within the hydrogel matrix mimicking those present in the native extracellular matrix that
promote cell attachment and bind to transmembrane integrin receptors on the cell surface.166 If
these adhesions sites aren’t present within the matrix, cells may remain viable but unable to
attach and spread throughout the matrix, resulting in a rounded morphology that prevents
migration and proliferation. Alginate, a polysaccharide derived from algae, is a widely used
biocompatible hydrogel material that has been reported to promote limited cell adhesion on its
own.173 Thus, alginate is commonly chemically modified with RGD peptide sequences or
combined with additional elements to provide cells with adhesion ligands to enhance cell
attachment.74,85 In this work, we originally incorporated polyvinyl alcohol and hydroxyapatite in
the form of a suspension into our alginate formulation to increase the biocompatibility and
promote cell attachment throughout the scaffolds. Polyvinyl alcohol has been reported to be
highly biocompatible polymer promoting cellular activities.55 Hydroxyapatite, as it is the main
mineral component in natural bone, was incorporated in the hydrogel to provide an environment
favorable for promoting MC3T3 cell differentiation into osteoblasts and enhancing calcium
phosphate deposition. It has also been reported that cells have the ability to attach to HA
particles.174,175

4.4.1.1 Effects of infill geometry
Scaffolds of varying infill geometries were 3D printed using a novel alginate-PVA-HA
formulation to investigate the effect of the geometry on cellular activities and proliferation. An
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original design with a honeycomb infill and 60% macro-porosity was first investigated, followed
by an alternating rectilinear infill design, also of 60% macro-porosity. A control formulation,
lacking the PVA-HA suspension, was included to determine the effect of the suspension on both
printability and cell proliferation. Figure 4.3 shows that MC3T3 cells encapsulated in the
alginate-PVA-HA formulation and 3D printed into scaffolds of original design showed a
constant reduction profile and thus limited proliferation in in vitro culture for 10 days. As a
significant decrease in cell number was not observed, it can be concluded that the cells are not
dying but are alive and merely abstaining from appropriate metabolic and physiological
activities, such as proliferation. This indicates that the formulation did not provide a favorable
enough environment suitable for substantial cell attachment and proliferation. As previously
discussed, cells must bind to the matrix via integrins in their cytoskeletons and ligands within the
matrix in order to form a network and proliferate sufficiently. Thus, although originally
hypothesized to be capable of promoting adhesion, the presence of the polyvinyl alcoholhydroxyapatite suspension alone was not enough to promote cell spreading and migration
necessary for proliferation. Similarly, cells encapsulated in scaffolds with the alternating infill
design showed limited proliferation throughout the scaffold within the 10 day time period.
Although drastic changes in infill geometry and porosity have been shown to affect proliferation
in PLA-collagen scaffolds for osteochondral regeneration, it was not observed in this study.139
This suggests that for our scaffolds, the material selection and lack of cell adhesion modalities
had a greater effect on proliferation than the infill design. When the control formulation was used
to print scaffolds of the original infill design, the resulting scaffolds lacked the intended macroporosity of the design. This is because the PVA-HA suspension provides the formulation with an
optimal viscosity for 3D printing scaffolds of high shape fidelity. Thus, control scaffolds
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supported slightly lower cell numbers than the scaffolds printed with the optimal formulation
throughout the in vitro study, but cells were still viable. Although the cells exhibited a slight
decrease in reduction from day 1 to day 4, suggesting cell death, the scaffolds did not decrease in
cell number for the remainder of the study. This suggests that the degree of microporosity within
the control scaffolds was sufficient to support cell life, but was unable to promote cell
proliferation, similar to scaffolds of the original and alternating infill designs.

4.4.1.2 Effects of calcium bath
As cell exposure to high concentrations of calcium has been reported to negatively affect
cellular activities, the concentration of the calcium bath in this study was reduced to 0.5 % (w/v)
CaCl2 in hope to increase cell proliferation throughout the scaffolds.159 Although a low
concentration of calcium is present in the cytoplasm to promote vital cell functions such as
attachment, motility and signal transduction, cell exposure to high concentrations of calcium for
extended periods of time has been reported to damage the cell membrane and even program cell
apoptosis.159,176 Thus, it was important that we investigate the effect of the calcium bath on cell
proliferation. Although an initial increase in cell number was observed on day 1 when the
concentration of the calcium bath was reduced, Figure 4.4 shows that an increase in proliferation
was still not observed for 7 days for cells 3D printed in scaffolds of either original or alternating
infill designs.

4.4.1.2.1 Calcium cytotoxicity analysis
To further investigate if the calcium bath had a negative effect on MC3T3 cell activity,
cells were seeded in a well plate and exposed to 0.5 % or 1.0 % (w/v) CaCl2 for 30 minutes. This
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simulated the incubation of the printed scaffolds in calcium baths for further crosslinking of the
alginate chains. As cells incubated in both calcium bath concentrations exhibited reduction levels
close to that of cells without incubation in calcium, shown in Figure 4.5, it can be concluded that
the metabolic activity of the cells was not significantly affected by exposure to calcium
concentrations of 0.5 % (w/v) and 1.0 % (w/v), agreeing with results reported in literature.98 Lee
et al. 76 showed that MC3T3 cells encapsulated in 1.0 % and 2.0 % alginate beads exposed to 1.0
% (w/v) CaCl2 for 1 hour displayed initial viability over 98 % and expressed substantial
proliferation in in vitro culture. Thus, in this case, the calcium bath at concentrations less than or
equal to 1.0 % (w/v) did not negatively affect the cells or inhibit their proliferation in 3D printed
scaffolds.

4.4.1.2.2 Scaffold diffusion properties
The release of FITC-dextran from 3D printed scaffolds was quantified in order to
determine whether the 3D printed scaffolds provided the encapsulated cells with sufficient
nutrient influx and waste removal to support cell life and appropriate physiological functions.
The extent of crosslinking of the alginate chains with calcium ions has an effect on the diffusion
properties of the resulting hydrogel. Calcium and other divalent cations bind with the carboxyl
and hydroxyl groups of the alginate G blocks in the polymer backbone to form egg box
structures.50 Lateral stacking of these egg boxes results in crosslinking and contraction of the
alginate matrix. Thus, during incubation in the calcium bath, calcium ions diffuse into the
scaffolds to further crosslink, resulting in shrinkage of the 3D printed scaffolds.
Figure 4.6a shows the release profile for each scaffold type over 3 days. For each scaffold
type, scaffolds incubated in 0.5 % (w/v) CaCl2 baths showed a greater release than those

99

incubated in 1.0 % (w/v) CaCl2 baths. This can be attributed to the fact that the lower calcium
concentration results in a lower degree of crosslinking and thus lower mechanical properties of
the scaffolds.38,155,177 Thus, the weaker scaffolds are prone to a greater degree of media intake
and swelling, leading to increased diffusion of the FITC-dextran out of the matrix and into the
surrounding media.178 Figure 4.6a also shows a greater final release of FITC-dextran for the
control scaffolds. Because the control scaffolds lack the intended macro-porosity exhibited by
the other scaffold designs, the calcium influx, crosslinking and scaffold shrinkage are minimal
during incubation in the calcium bath. As diffusion is limited during this period, there was
minimal release of FITC-dextran from the matrix out into the calcium bath. Thus, a greater
amount of FITC-dextran was released for the remainder of the study. Similarly, it can be inferred
from the release profile that the scaffolds of the alternating infill design released the most FITCdextran during the calcium bath. This can be due to the fact that the alternating design resulted in
scaffolds of increased interconnected infill with the same degree of porosity. Thus, the scaffolds
exhibited a greater degree of crosslinking during this time period, resulting in a greater amount
of FITC-dextran being squeezed out of the matrix into the surrounding media. Scaffolds of the
alternating infill design reach lower cumulative release values for the remainder of the study as
there was less FITC-dextran to start with after the calcium bath. Scaffolds of the original infill
design exhibited an intermediate release value as the macro-porosity allowed release of FITCdextran during the calcium bath but not to the extent reached by scaffolds of the alternating infill
design. Thus, a greater amount of FITC-dextran was released from scaffolds of the original infill
design compared to the alternating infill design for the remainder of the study.
The permeability and diffusion coefficients of FITC-dextran released from the 3D printed
scaffolds of various infill geometries were determined using the linear region of the initial 1.5
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hours in incubation in after the calcium bath, seen in Figure 4.6b. Figure 4.7 shows the
permeability coefficients and Table 4.1 reports the diffusion coefficients of FITC-dextran. All
values are greater than those reported in literature, indicating the scaffolds are sufficient for
proper nutrient diffusion and waste removal to support cell life.179,180 As previously discussed,
the scaffolds of the alternating infill design released the most FITC-dextran in the calcium bath,
resulting in a lower permeability coefficient for the following incubation period. For each
scaffold type, the permeability is greater for scaffolds crosslinked in the 0.5 % (w/v) CaCl2 bath
compared to those in the 1.0 % (w/v) CaCl2 bath as expected. As previously described, this is due
to the lower degree of crosslinking as a result of the formation of fewer calcium alginate bonds.
As all scaffold types exhibit sufficient diffusivity to support cellular life and activities in
in vitro culture, it can be concluded that the extent of crosslinking and thereby diffusion
properties of the 3D printed scaffolds are not deterring the encapsulated cells from proliferating
throughout the matrix.

4.4.1.3 Effect of collagen content
Collagen was incorporated into the hydrogel formulation to provide the encapsulated
cells with adhesion ligands necessary to promote cellular attachment, as collagen is a ligand
present in the native extracellular matrix that binds with integrins on the cytoskeleton.181,182 The
incorporation of collagen did not significantly affect the viscosity and thus printability of the
hydrogel formulation. In order for a scaffold of high shape fidelity to be printed, it is of the most
importance that the hydrogel be continuously extruded and not too viscous to clog the needle.170
Also, it must not negatively impact the capability of the formulation to protect the encapsulated
cells throughout the printing process and shield them from the shear stresses applied during
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extrusion.97 As the collagen was incorporated in a gel state, it did not impose additional stress or
difficulties during printing.
Initially, the addition of 5.0 % (w/v) collagen to 3D bioprinted scaffolds of the alternating
infill design that were incubated in 0.5 % (w/v) CaCl2 bath for 1 hour showed a slight increase in
proliferation until day 4 but remained relatively constant for the remainder of the study, seen in
Figure 4.8a. A decrease in the calcium bath duration and addition of a rinsing step resulted in an
increase in cell number on day 1, providing a more favorable initial environment for cell
survival. However, the cell number remained constant throughout the study as before. As the
mechanical properties of the scaffold also play a critical role in affecting cell proliferation, the
concentration of the calcium bath was increased to 1.0 % (w/v) CaCl2 to provide the scaffold
with enhanced crosslinking as well as stiffness. This achieved a proliferation profile more closely
resembling that as expected, with a slight increase in cell number until day 7 followed by a slight
decrease on day 10. The addition of the rinsing step to remove excess calcium ions resulted in a
slight increase in cell number until day 10. Although the collagen showed promise in improving
cell proliferation throughout the scaffolds, the limited increase in cell number suggested that the
hydrogel matrix composition could be modified further to achieve a more optimal environment
for enhancing cell proliferation and natural physiological behaviors. Thus, the collagen content
was further increased to provide the cells with increased ligand binding site density in hope to
enhance attachment and proliferation.
An increase in collagen content to 6.5 % (w/v) in scaffolds incubated in 0.5 % (w/v)
CaCl2 bath for 30 minutes did not have a significant effect on proliferation, shown in Figure
4.8b. Although the cells were provided with an increase in ligand density and thus initial
attachment sites, the lower amount of calcium ions available in the bath resulted in the formation
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of fewer crosslinks. This proved the importance of the synergistic presence of ligands and
scaffold mechanical rigidity as soft scaffolds were unable to support proliferation.184 When the
calcium bath concentration was increased to 1.0 % (w/v) CaCl2, an increase in reduction and thus
cell proliferation was observed until day 7 in culture. The increased collagen content and
alginate-calcium crosslinks offered a scaffold with sufficient adhesion ligands and appropriate
mechanical rigidity necessary for cells to attach and proliferate. The slight decrease in cell
number, although not significant, observed on day 10 can be attributed to a decrease in metabolic
activity. MC3T3 cells have been reported to reach a quiescent state by day 9 in in vitro
culture.183 At this point, they exit the G1 cellular growth phase, and enter the G0 phase in which
the cells stop dividing and lose their metabolic activity. As alamarBlue is a measure of metabolic
activity and a cell’s ability to reduce resazurin, a decrease in reduction at day 10 doesn’t signify
cell death but cell maturation. At this stage, an external stimuli is necessary to induce the cells to
proceed with differentiation. Thus, it can be inferred that the MC3T3 cells in the 3D printed
scaffolds are ready for differentiation. However, external biological cues and osteogenic media
including ascorbic acid and β-glycerophosphate are necessary to promote differentiation into
osteoblasts. Thus, the 3D printed scaffolds with increased collagen content and appropriate
mechanical rigidity have a great potential to support cellular proliferation and achievement of a
state ready for differentiation.

4.4.2 Mechanical properties
Mechanical rigidity and integrity of the 3D printed scaffolds also has a significant effect
on the ability of cells to effectively attach to and proliferate throughout the matrix.184,185 Figure
4.9 shows that after 1 day in culture, scaffolds incubated in 1.0 % CaCl2 exhibited higher
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compressive moduli values than those incubated in 0.5 % CaCl2. This can be attributed to the
increased calcium content available to crosslink the alginate chains, as previously discussed.
With increased time in culture, scaffolds incubated in both calcium concentrations exhibited a
decrease in compressive modulus, due to ion exchange between calcium ions involved in the
crosslinking with alginate carboxyl groups with sodium ions in the surrounding media.38 Thus, as
crosslinks are broken, scaffolds uptake media, swell, and lose their mechanical stability. It was
determined that the increase in initial crosslinks throughout the scaffolds incubated in 1.0 %
CaCl2 baths provided the mechanical stability necessary that when coupled with the increased
collagen and thus ligand content resulted in the most favorable environment for cell proliferation.
Scaffolds incubated in 1.0 % CaCl2 provided a more rigid matrix on day 7 which is a crucial time
point for cell proliferation and migration. The matrix needs to provide the cells with a rigid
substrate to withstand the contractile forces imposed by cells during migration.186,187 Thus, a
synergistic effect exists in which the mechanical properties coupled with the biological
environment must both be sufficient for the cells to achieve significant proliferation.
As MC3T3 cells are pre-osteoblasts in origin, they prefer and achieve optimal
proliferation on stiff substrates with compressive moduli closer to that of natural bone.188 Thus, a
further increase in the compressive modulus of the scaffolds may result in a more optimal
environment to promote proliferation and differentiation of MC3T3 cells. This could be achieved
by increasing the hydroxyapatite content in the formulation as long as the viscosity and
printability of the hydrogel isn’t affected.
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4.4.3 Conclusions
In the work described in this chapter, we have systematically investigated methods to
increase the proliferation of MC3T3 cells 3D printed into scaffolds composed of a novel
hydrogel formulation. It was determined that only the synergistic effect of sufficient ECM ligand
density coupled with proper mechanical rigidity provided a suitable environment for
proliferation. The enhanced collagen content was necessary to provide the cells with sufficient
attachment sites to the matrix while the increased calcium content in the calcium bath was
necessary to provide sufficient crosslinking and adequate mechanical resistance to withstand cell
contractile forces necessary for proper migration. Separately, these factors did not promote cell
proliferation. It was determined that all scaffolds exhibited diffusion properties to necessary
support sufficient nutrient influx and waste removal. The proliferation profile achieved by
MC3T3 cells 3D printed in scaffolds with increased collagen content suggests that by day 10 in
culture the cells are waiting to receive external cues to begin differentiation. Thus, future in vitro
differentiation and in vivo studies must be conducted to determine if the MC3T3 cells have
maintained their natural physiological functions and bone making capabilities after 3D printing
and crosslinking of the scaffolds. This in vitro evaluation of our novel 3D printed tri-polymer
alginate-PVA-HA-collagen scaffolds shed light on the scaffolds’ ability to support cell viability
and potential to promote differentiation in future studies.
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Chapter 5
Conclusions and Future work

5.1 Conclusions
In this work, novel alginate hydrogel systems were developed to aid in the progression of
more personalized methods for treating defective bone tissue. The gelation properties of alginate
hydrogel formulations were thoroughly investigated and control of gelation kinetics was
established through introduction of a retardation agent as well as by varying the concentrations
of the constituents. A novel alginate-collagen-hydroxyapatite hydrogel formulation was
developed with a gelation time suitable in a surgical setting. Novel in situ formation of this
system results in an environment more closely mimicking that of natural bone, and has potential
as an injectable bone tissue substitute through less invasive means. Not only can this system be
implemented to fill irregular bone defects and breaks but it can be implemented to fill areas of
osteoporotic bone as well. This would promote healing of the area and prevent further
progression of the weakened bone and future injuries by inducing formation of new, strong bone.
The unique gelation properties also allow incorporation of drugs and/or cells to treat osteoporosis
and enhance further new bone formation.
The innate material properties and versatility of alginate then allowed translation of the
novel hydrogel system to application in the ever-growing, popular field of 3D printing
technology. A systematic investigation was conducted and a novel alginate-polyvinyl alcoholhydroxyapatite hydrogel formulation suitable for 3D printing scaffolds of high shape fidelity was
developed. Rheology of the formulations was completed to understand the differences in storage
moduli associated with printability and determine what range enabled the hydrogel to be easily
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extruded and recover upon deposition, forming scaffolds of high shape fidelity. The degradation
properties of the scaffolds were then investigated and it was determined that scaffolds
maintained integrity over 14 days in culture, indicating they are capable of physically supporting
cell life over this time period. Most importantly, live MC3T3 cells were incorporated into the
optimal alginate-PVA-HA hydrogel formulation and 3D printed at high viability rates.
Collectively, the results of this study suggest that this formulation has potential to 3D bioprint
structures capable of supporting cell life in culture, with the novel composition providing an
environment favorable of promoting tissue regeneration.
Finally, in vitro studies were conducted to assess the scaffolds’ ability to promote
proliferation of MC3T3 cells and potential for their differentiation into osteoblasts. Initial results
showed limited proliferation of cells encapsulated in the original alginate-PVA-HA scaffolds.
Further efforts to increase proliferation showed that the concentration and duration of the
calcium bath have a less effect on proliferation than the composition of the formulation itself.
Thus, a novel alginate-PVA-HA-collagen tri-polymer formulation was developed, providing an
environment most favorable for proliferation. It was determined that this was due to the
synergistic effect presented by the presence of increased adhesion ligand density within the
collagen with the increased mechanical properties as a result of increased crosslinking. This
systematic investigation shed light on properties of the hydrogel formulation and resulting
scaffolds necessary for MC3T3 proliferation and developed an environment with potential to
promote differentiation and thereby new bone formation.
Thus, the development of these alginate hydrogel systems can provide opportunities for
enhanced, uniform, personalized healing of defective bone tissue due to their gelation properties
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suitable for various applications and superior compositions incorporating collagen and
hydroxyapatite, the two main components of natural bone.

5.2 Future work
5.2.1 Drug delivery
To expand the applications of the alginate hydrogel systems, their use in drug delivery
may be investigated. Model drugs or proteins, such as bovine serum albumin (BSA), may be
incorporated into the alginate suspension before the addition of the calcium sulfate for
encapsulation at levels of high efficiency within the alginate matrix. The formulation then may
be either 3D printed and further crosslinked or be injected into an irregular mold to set before
incubation in a waterbath at 37 °C for 7-14 days. The model drugs or proteins may be conjugated
with fluorescent molecules such as Alexa Fluor 488 or FITC so that their release from the matrix
into the surrounding media can be quantified via absorbance, read with a spectrometer. The burst
release and/or sustained release profiles can then be determined and the hydrogel system’s
capacity as a drug carrier can be determined. Potential applications include incorporation of
alendronate, a biophosphonate that hinders bone resorption of osteoclasts, into the alginate
matrix for sustained release to help treat osteoporosis.

5.2.2 3D printing scaffolds of irregular architectures
As it is of interest to apply 3D printing of these novel alginate hydrogel scaffolds in a
clinical setting, the ability of the hydrogel formulation to 3D print large scaffolds with irregular
geometries and high shape fidelity should be investigated. Such scaffolds would possess a
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jagged, irregular perimeter and size more closely resembling those of a natural bone defect. An
example of the proposed scaffold is presented in Figure 5.1.

a)

b)

Figure 5.1: Example of a) CAD model and b) sliced .stl file of proposed irregular scaffold design

Once scaffolds of such architecture are 3D printed with high shape fidelity, application
for bioprinting large scale, personalized scaffolds from a patient’s CT scan or MRI can be
employed. Thus, reconstruction and repair of non-load bearing, such as craniofacial, bone tissue
can be achieved.
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5.2.3 Further in vitro evaluation
Before the tri-polymer 3D bioprinted scaffolds can be implemented for bone healing in
vivo, further in vitro evaluations must be completed to assess the scaffolds ability to promote
differentiation of MC3T3 cells into osteoblasts and thus deposition of new bone. 3D printed
scaffolds should be cultured in osteogenic media, in the presence of ascorbic acid and βglycerophosphate, for 14 to 21 days. Levels of alkaline phosphatase (ALP), a by-product of
osteoblast activity, can be quantified throughout the study via a colormetric assay kit.
P-nitrophenol phosphate (pNNP) is dephosphorylated in the presence of ALP and can be
quantified via absorbance measurements. Absorbance values can be directly correlated to the
amount of ALP secreted by the cells, which is increased when osteoblasts are depositing new
bone.
Levels of RUNX2, a protein reflecting MC3T3 differentiation into osteoblasts, can also
be measured via PCR analysis through the duration of in vitro studies. RUNX2 is an early
marker of bone formation as it is upregulated in immature osteoblasts, and should show an
increase at about 14 days in culture.
Levels of osteocalcin and osteopontin, proteins produced by mature osteoblasts, can be
measured as late markers of bone formation via ELISA kits. Osteocalcin is a non-collagenous
protein in bone. Osteopontin is an organic, extracellular structural protein in bone that strongly
binds to calcium based minerals, playing a vital role in bone remodeling by anchoring osteoclasts
to the mineral matrix of bone. Increased levels of both proteins reflect an increase in bone
density, which should occur through 14-21 days in culture. Additionally, at this stage histology
can be conducted to obtain physical sections and assess the quality of new bone tissue formation.
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5.2.4 In vivo evaluation
Once 3D bioprinted scaffolds show successful promotion of MC3T3 differentiation into
osteoblasts and express significant signs of new bone formation in vitro, movement can be made
towards in vivo testing. Tri-polymer scaffolds encapsulating MC3T3 cells of either conventional
or irregular architecture can be 3D printed and implanted into rat calvarial bone tissue defects of
matching geometry. New bone formation can then be monitored and evaluated over 2 months via
histology, assessing the scaffolds capability to promote bone tissue regeneration in vivo.
Completion of in vivo studies would thus contribute to possible alternative methods to treat
personalized bone defects of patients in need of bone healing or reconstruction.
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